QuickLinks -- Click here to rapidly navigate through this document

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549



FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 20, 2015

CF Industries Holdings, Inc.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction
of incorporation)
  001-32597
(Commission
File Number)
  20-2697511
(I.R.S. Employer
Identification No.)
4 Parkway North, Suite 400
Deerfield, Illinois

(Address of principal
executive offices)
 
60015

(Zip Code)

Registrant's telephone number, including area code: (847) 405-2400

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

ý
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 1.01    Entry into a Material Definitive Agreement.

        On December 20, 2015, CF Industries Holdings, Inc., a Delaware corporation ("CF"), entered into a Second Amendment to the Combination Agreement (the "Second Amendment to the Combination Agreement") by and among CF, Darwin Holdings Limited, a private company limited by shares incorporated under the law of England ("Darwin Holdings"), Beagle Merger Company LLC, a Delaware limited liability company and wholly-owned, direct or indirect subsidiary of Darwin Holdings ("Beagle MergerCo"), OCI N.V., a public company with limited liability ( naamloze vennootschap ) incorporated under the law of the Netherlands ("OCI"), CF B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated under the law of the Netherlands ("New CF") and Finch Merger Company LLC, a Delaware limited liability company and wholly-owned, direct or indirect, subsidiary of New CF ("MergerCo").

        The Second Amendment to the Combination Agreement amends the combination agreement, dated as of August 6, 2015 (as amended on November 6, 2015, the "Original Agreement", as amended on November 6, 2015 and December 20, 2015, the "Combination Agreement"), by and among CF, Darwin Holdings, Beagle MergerCo and OCI, to, among others, reflect the addition of New CF and MergerCo as parties to the Original Agreement and to remove Darwin Holdings and Beagle MergerCo as parties to the Original Agreement.

        In connection with the Second Amendment to the Combination Agreement, New CF also entered into an Amended and Restated Shareholders' Agreement (the "Amended and Restated Shareholders' Agreement"), by and among New CF, OCI, Capricorn Capital B.V., a private limited company incorporated under the law of the Netherlands ("Capricorn"), Leo Capital B.V., a private limited company incorporated under the law of the Netherlands ("Leo") and Aquarius Investments B.V., a private limited company incorporated under the law of the Netherlands (together with Leo and Capricorn, the "Shareholders"). The Amended and Restated Shareholders' Agreement amends the Shareholders' Agreement (the "Shareholders' Agreement"), dated as of August 6, 2015, by and among Darwin Holdings, OCI and the Shareholders to, among others, add New CF as a party to the agreement and to remove Darwin Holdings as a party. The Amended and Restated Shareholders' Agreement also removed (i) the director appointment rights previously provided in the Shareholders' Agreement and (ii) the Shareholders' obligation, subject to certain exceptions, to vote in accordance with the recommendation of the board of directors of New CF.

        The Irrevocable Undertakings that CF and OCI entered into with each of the Shareholders remain in effect.

        The Combination Agreement and Amended and Restated Shareholders' Agreement (the "Agreements") contain representations and warranties by the parties thereto. These representations and warranties were made solely for the benefit of the other parties to such Agreement and (i) were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) may have been qualified in the applicable Agreement by disclosures that were made to the other party in connection with the negotiation of such Agreement; (iii) may apply contract standards of "materiality" that are different from "materiality" under the applicable securities laws; and (iv) were made only as of the date of the applicable Agreement or such other date or dates as may be specified in such Agreement. CF acknowledges that, notwithstanding the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional specific disclosures of material information regarding material contractual provisions are required to make the statements in this Current Report on Form 8-K not misleading.

        The foregoing descriptions of the Combination Agreement and the Amended and Restated Shareholders' Agreement do not purport to be complete and are qualified in their entirety by reference

1


to the Agreements, copies of which are attached as Exhibit 2.1 and 2.2, respectively, hereto and are incorporated herein by reference.

NO OFFER OR SOLICITATION

        This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

ADDITIONAL INFORMATION

        The new holding company ("New CF") for the combination of CF Industries Holdings, Inc. ("CF Industries") and the European, North American and global distribution businesses of OCI N.V. ("OCI") will file with the SEC an amended registration statement on Form S-4 (SEC File No. 333-207847) that will include a preliminary proxy statement of CF Industries and a preliminary shareholders circular of OCI, each of which will also constitute a preliminary prospectus of New CF. The registration statement has not been declared effective by the SEC. The definitive proxy statement/prospectus will be delivered to CF Industries shareholders and the definitive shareholders circular/prospectus will be delivered to OCI shareholders as required by applicable law after the registration statement becomes effective. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS, THE SHAREHOLDERS CIRCULAR/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the proxy statement/prospectus, the shareholders circular and other documents filed with the SEC by New CF and CF Industries through the website maintained by the SEC at www.sec.gov. In addition, investors and security holders will be able to obtain free copies of the proxy statement/prospectus, the shareholders circular and other documents filed by CF Industries and New CF with the SEC by contacting CF Industries Investor Relations at: CF Industries Holdings, Inc., c/o Corporate Communications, 4 Parkway North, Suite 400, Deerfield, Illinois, 60015 or by calling (847) 405-2542.

PARTICIPANTS IN THE SOLICITATION

        CF Industries and New CF and their respective directors and executive officers and OCI and its executive directors and non-executive directors may be deemed to be participants in the solicitation of proxies from the stockholders of CF Industries in connection with the proposed transaction. Information regarding the directors and executive officers of CF Industries is contained in CF Industries' proxy statement for its 2015 annual meeting of stockholders, filed with the SEC on April 2, 2015, and CF Industries' Current Report on Form 8-K filed with the SEC on June 25, 2015. Information about the executive directors and non-executive directors of OCI is contained in OCI's annual report for the year ended December 31, 2014, available on OCI's web site at www.oci.nl. Other information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the stockholders of CF Industries in connection with the proposed transaction, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in the preliminary proxy statement/prospectus included in the registration statement on Form S-4 filed by Darwin Holdings Limited on November 6, 2015 (SEC File No. 333-207847).

2


FORWARD-LOOKING STATEMENTS

        All statements in this communication by CF Industries Holdings, Inc. (together with its subsidiaries, the "Company"), other than those relating to historical facts, are forward-looking statements. Forward-looking statements can generally be identified by their use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict" "project" and similar terms and phrases, including references to assumptions. Forward-looking statements are not guarantees of future performance and are subject to a number of assumptions, risks and uncertainties, many of which are beyond the Company's control, which could cause actual results to differ materially from such statements. These statements may include, but are not limited to, statements about the benefits, expected timing of closing and other aspects of the proposed acquisition (the "OCI Transaction") by the Company from OCI N.V. ("OCI") of OCI's European, North American and global distribution businesses (the "ENA Business") and the proposed strategic venture (the "CHS Strategic Venture") with CHS Inc. ("CHS"); statements about future strategic plans; and statements about future financial and operating results.

        Important factors that could cause actual results to differ materially from those in the forward-looking statements include, among others, risks and uncertainties arising from the possibility that the CHS Strategic Venture as contemplated may be delayed or may not take effect at all; difficulties associated with the operation or management of the CHS Strategic Venture; risks and uncertainties relating to the market prices of the fertilizer products that are the subject of the supply agreement over the life of the supply agreement and risks that disruptions from the CHS Strategic Venture as contemplated will harm the Company's other business relationships; the volatility of natural gas prices in North America and Europe; the cyclical nature of the Company's business and the agricultural sector; the global commodity nature of the Company's fertilizer products, the impact of global supply and demand on the Company's selling prices, and the intense global competition from other fertilizer producers; conditions in the U.S. and European agricultural industry; difficulties in securing the supply and delivery of raw materials, increases in their costs or delays or interruptions in their delivery; reliance on third party providers of transportation services and equipment; the significant risks and hazards involved in producing and handling the Company's products against which the Company may not be fully insured; risks associated with cyber security; weather conditions; the Company's ability to complete its production capacity expansion projects on schedule as planned, on budget or at all; risks associated with expansions of the Company's business, including unanticipated adverse consequences and the significant resources that could be required; potential liabilities and expenditures related to environmental, health and safety laws and regulations and permitting requirements; future regulatory restrictions and requirements related to greenhouse gas emissions; the seasonality of the fertilizer business; the impact of changing market conditions on the Company's forward sales programs; risks involving derivatives and the effectiveness of the Company's risk measurement and hedging activities; the Company's reliance on a limited number of key facilities; risks associated with the Company's Point Lisas Nitrogen Limited joint venture; acts of terrorism and regulations to combat terrorism; risks associated with international operations; losses on the Company's investments in securities; deterioration of global market and economic conditions; and the Company's ability to manage its indebtedness.

        Other important factors, relating to the OCI Transaction, that could cause actual results to differ materially from those in the forward-looking statements include, among others: the risk that the OCI Transaction is not accorded the tax and accounting treatment anticipated by the Company; the effect of future regulatory or legislative actions on the new holding company ("New CF"), the Company and the ENA Business; risks and uncertainties relating to the ability to obtain the requisite approvals of stockholders of the Company and OCI with respect to the OCI Transaction; the risk that governmental or regulatory actions delay the OCI Transaction or result in the imposition of conditions that could reduce the anticipated benefits from the OCI Transaction or cause the parties to abandon the OCI

3


Transaction; the risk that a condition to closing of the OCI Transaction may not be satisfied; the length of time necessary to consummate the OCI Transaction; the risk that the Company and the ENA Business are subject to business uncertainties and contractual restrictions while the OCI Transaction is pending (including the risk that the Company is limited from engaging in alternative transactions and could be required in certain circumstances to pay a termination fee); the risk that the OCI Transaction or the prospect of the OCI Transaction disrupts or makes it more difficult to maintain existing relationships or impedes establishment of new relationships with customers, employees or suppliers; diversion of management time on transaction-related issues; the risk that New CF, the Company and the ENA Business are unable to retain and hire key personnel; the risk that closing conditions related to the Natgasoline joint venture may not be satisfied; the risk that the Company, New CF and the ENA Business will incur costs related to the OCI Transaction that exceed expectations; the risk that the businesses of the Company and the ENA Business will not be integrated successfully; the risk that the cost savings and any other synergies from the OCI Transaction may not be fully realized or may take longer to realize than expected; the risk that access to financing, including for refinancing of indebtedness of the ENA Business or the Company, may not be available on a timely basis and on reasonable terms; unanticipated costs or liabilities associated with the OCI Transaction-related financing; the risk that the credit ratings of New CF and the Company, including such ratings taking into account the OCI Transaction and related financing, may differ from the Company's expectations; risks associated with New CF's management of new operations and geographic markets; and the risk that the ENA Business is unable to complete its current production capacity development and improvement projects on schedule as planned, on budget or at all.

        More detailed information about factors that may affect the Company's performance and could cause actual results to differ materially from those in any forward-looking statements may be found in CF Industries Holdings, Inc.'s filings with the Securities and Exchange Commission (the "SEC"), including CF Industries Holdings, Inc.'s most recent periodic report filed on Form 10-Q, which is available in the Investor Relations section of the Company's web site. Forward-looking statements are given only as of the date of this communication and the Company disclaims any obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

4


Item 9.01    Financial Statements and Exhibits.

(d)
Exhibits.

Exhibit No.   Description
  2.1   Second Amendment to the Combination Agreement, dated December 20, 2015, by and among CF Industries Holdings, Inc., Darwin Holdings Limited, Beagle Merger Company LLC, OCI N.V., CF B.V. and Finch Merger Company LLC(1)
  2.2   Second Amendment to the Shareholders' Agreement, dated December 20, 2015, by and among Darwin Holdings Limited, OCI N.V., CF B.V., Capricorn Capital B.V., Leo Capital B.V., and Aquarius Investments B.V.

   


(1)
Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. CF hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the U.S. Securities and Exchange Commission.


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 23, 2015            

 

 

CF INDUSTRIES HOLDINGS, INC.

 

 

By:

 

/s/ DOUGLAS C. BARNARD

        Name:   Douglas C. Barnard
        Title:   Senior Vice President, General Counsel, and Secretary


EXHIBIT INDEX

Exhibit No.   Description
  2.1   Second Amendment to the Combination Agreement, dated December 20, 2015, by and among CF Industries Holdings, Inc., Darwin Holdings Limited, Beagle Merger Company LLC, OCI N.V., CF B.V. and Finch Merger Company LLC(2)
  2.2   Second Amendment to the Shareholders' Agreement, dated December 20, 2015, by and among Darwin Holdings Limited, OCI N.V., CF B.V., Capricorn Capital B.V., Leo Capital B.V., and Aquarius Investments B.V.

   


(2)
Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. CF hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the U.S. Securities and Exchange Commission.



QuickLinks

SIGNATURES
EXHIBIT INDEX

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 2.1

SECOND AMENDMENT TO COMBINATION AGREEMENT

        THIS SECOND AMENDMENT, dated as of December 20, 2015 (this " Second Amendment "), to the Combination Agreement, dated as of August 6, 2015 (the " Original Agreement "), by and among CF Industries Holdings, Inc., a Delaware corporation (" Cambridge "), Darwin Holdings Limited, a private company limited by shares incorporated under the law of England (" Darwin Holdings "), Beagle Merger Company LLC, a Delaware limited liability company (" Beagle MergerCo "), OCI N.V., a public company with limited liability ( naamloze vennootschap ) incorporated under the law of the Netherlands (" Oxford "), CF B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated under the law of the Netherlands, with its corporate seat ( statutaire zetel ) in Amsterdam, the Netherlands (" Holdco ") and Finch Merger Company LLC, a Delaware limited liability company and wholly-owned, direct or indirect, subsidiary of Holdco (" MergerCo "). Each of Cambridge, Oxford, Darwin Holdings and Beagle MergerCo are referred to herein as a " Party " and together the " Parties ". Capitalized terms used but not defined herein shall have the meanings given to such terms in the Combination Agreement.


W I T N E S S E T H :

        WHEREAS, the Parties entered into the Original Agreement;

        WHEREAS, the Parties entered into an Amendment to the Original Agreement, dated as of November 6, 2015 (the " Amendment ", and the Original Agreement as amended by the Amendment, the " Combination Agreement ");

        WHEREAS, the Parties desire to amend the Combination Agreement to reflect the addition of CF B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated under the law of the Netherlands, with its corporate seat ( statutaire zetel ) in Amsterdam, the Netherlands, and Finch Merger Company LLC, a Delaware limited liability company, as parties to the Combination Agreement and to remove Darwin Holdings and Beagle MergerCo as parties to the Combination Agreement;

        WHEREAS, after giving effect to this Second Amendment, all references in the Combination Agreement to " Holdco " shall mean CF B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated under the law of the Netherlands, with its corporate seat ( statutaire zetel ) in Amsterdam, the Netherlands;

        WHEREAS, after giving effect to this Second Amendment, all references in the Combination Agreement to " MergerCo " shall mean Finch Merger Company LLC, a Delaware limited liability company; and

        WHEREAS, pursuant to Section 12.7 of the Combination Agreement, the Parties desire to amend certain terms of the Combination Agreement, as set forth in this Second Amendment.

        NOW, THEREFORE, in consideration of the foregoing promises and other good and valuable consideration, the receipt and sufficiency of which are hereby expressly acknowledged, and subject to the terms and conditions hereof, the parties hereto agree as follows:

1.
The Preamble is hereby amended and restated in its entirety to read as follows:

2.
The tenth Recital is hereby amended and restated in its entirety to read as follows:
3.
The eleventh Recital is hereby amended and restated in its entirety to read as follows:
4.
Section 1.1 is hereby amended and restated in its entirety to read as follows:
5.
Section 2.5(d) is hereby amended and restated in its entirety to read as follows:
6.
Section 2.7(e) is hereby amended and restated in its entirety to read as follows:

2


7.
Section 3.2(a) is hereby amended and restated in its entirety to read as follows:
8.
Section 3.2(b) is hereby amended and restated in its entirety to read as follows:
9.
Section 3.2(c)(i) is hereby amended and restated in its entirety to read as follows:
10.
Section 3.2(d) is hereby deleted in its entirety.

11.
Section 3.3(a) is hereby amended and restated in its entirety to read as follows:
12.
Section 3.3(f)(i) is hereby amended and restated in its entirety to read as follows:
13.
The representations and warranties set forth in Sections 4.1(a), 4.2, 4.5 and 4.7 of the Combination Agreement are incorporated herein by reference, and, subject to the qualifications and limitations set forth in the introductory paragraph of Article IV, Oxford represents and warrants to Cambridge

3


14.
Section 4.6 is hereby amended and restated in its entirety to read as follows, and Oxford represents and warrants as of the date hereof to Cambridge:
15.
The representations and warranties set forth in Sections 5.1, 5.2, 5.4 and 5.6 of the Combination Agreement are incorporated herein by reference, and, subject to the qualifications and limitations set forth in the introductory paragraph of Article V, Cambridge represents and warrants to Oxford as set forth in such sections as so incorporated by reference. From and after the date of this Second Amendment, any reference to any such section in the Agreement as amended hereby shall, unless the context requires otherwise, be deemed to refer both to such section in the Combination Agreement as amended hereby and to such section so incorporated by reference into this Second Amendment (it being understood that the phrases "as of the date of the Agreement" and "as of the date hereof" and similar phrases in the Combination Agreement as amended hereby shall, in reference to such sections as so incorporated by reference into this Second Amendment, be deemed to refer to the date of this Second Amendment).

16.
Section 5.5 is hereby amended and restated in its entirety to read as follows, and Cambridge represents and warrants as of the date hereof to Oxford:

4


17.
Section 6.3(b) is hereby amended and restated in its entirety to read as follows:
18.
Article VI of the Combination Agreement is incorporated herein by reference, and Holdco represents and warrants as of the date hereof to Cambridge and Oxford as set forth in such Article as so incorporated by reference (it being understood that the phrases "as of the date of the Agreement" and "as of the date hereof" and similar phrases in the Combination Agreement as amended hereby shall, in reference to such sections as so incorporated by reference into this Second Amendment, be deemed to refer to the date of this Second Amendment).

19.
Section 7.1(b)(2) is hereby amended and restated in its entirety to read as follows:
20.
Section 7.2(iii) is hereby amended and restated in its entirety to read as follows:
21.
Section 7.20(e) is hereby amended and restated in its entirety to read as follows:
22.
Section 9.1 is hereby amended and restated in its entirety to read as follows:

5


23.
Section 10.1(l) is hereby amended and restated in its entirety to read as follows:
24.
Section 10.1(m) is hereby amended and restated in its entirety to read as follows:
25.
Section 10.2 is hereby amended by appending a new subsection (h) thereto which reads in its entirety as follows:
26.
Section 11.1(b)(i) is hereby amended by inserting "Section 10.1(c)," immediately before "Section 10.1(d)".

27.
Section 11.1(c)(iii) is hereby amended and restated in its entirety to read as follows:
28.
The following definition is hereby deleted in its entirety from Article XIII:
29.
The following definitions are hereby added to Article XIII:
30.
Exhibit A to the Combination Agreement is hereby amended and restated in its entirety to read as set forth in Exhibit A hereto.

6


31.
Exhibit C to the Combination Agreement is hereby amended and restated in its entirety to read as set forth in Exhibit B hereto.

32.
Exhibit D to the Combination Agreement is hereby amended and restated in its entirety to read as set forth in Exhibit C hereto.

33.
Exhibit E to the Combination Agreement is hereby amended and restated in its entirety to read as set forth in Exhibit D hereto.

34.
The Oxford Disclosure Letter is hereby amended as set forth in Annex A hereto.

35.
Competition Matters . It is the present expectation of each of the Parties that no further filings or notifications will be required on or after the date hereof under the HSR Act, European Merger Regulation or Turkish Competition Authority ( Rekabet Kurumu ).

36.
Waiver of Right to Terminate . Each of Cambridge and Oxford hereby waive the right to terminate the Combination Agreement pursuant to Section 11.1(b)(v) as result of Notice 2015-79 issued by the Department of the Treasury and Internal Revenue Service on November 19, 2015.

37.
Combination Agreement in Full Force and Effect . Except as expressly provided hereby, this Second Amendment shall not constitute a waiver or amendment of any term or condition of the Combination Agreement, or the documents delivered pursuant thereto, and all such terms and conditions shall remain in full force and effect and are hereby ratified and confirmed in all respects. Upon the execution hereof, the Amendment, this Second Amendment and the Original Agreement shall constitute one agreement. The term " Agreement ", as used in the Combination Agreement, shall mean the Original Agreement as amended by the Amendment and this Second Amendment, although this change shall not alter the dates as of which any provision of the Agreement speaks, except as expressly provided herein. For example, phrases such as "as of the date hereof" and "as of the date of this Agreement" shall continue to refer to August 6, 2015, the date that the Original Agreement was executed, except as expressly provided herein.

38.
Release . Each of the Parties, other than Darwin Holdings and Beagle MergerCo, hereby irrevocably and unconditionally releases and forever discharges Darwin Holdings and Beagle MergerCo and their respective Affiliates and each of their respective Representatives, successors and assigns (collectively, the " Releasees ") from any and all claims or proceedings, whether or not now known or anticipated, which the Parties, other than Darwin Holdings and Beagle MergerCo, now have, have ever had or may hereafter have against the Releasees with respect to, relating to or arising from the Agreement.

39.
Counterparts; Effectiveness . This Second Amendment may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which, when taken together, shall constitute one and the same instrument. This Second Amendment shall become effective when each party hereto shall have received counterparts thereof signed and delivered by the other parties hereto. Signatures transmitted electronically shall be accepted as originals for all purposes of this Second Amendment.

[ Signature pages follow ]

7


        IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to be executed as of the date first written above.

    CF INDUSTRIES HOLDINGS, INC.

 

 

By:

 

/s/ W. ANTHONY WILL

Name: W. Anthony Will
Title:
President and Chief Executive Officer

[Signature Page to Amendment No. 2 to Combination Agreement]


    DARWIN HOLDINGS LIMITED

 

 

By:

 

/s/ DOUGLAS C. BARNARD

Name: Douglas C. Barnard
Title:
Managing Director

    BEAGLE MERGER COMPANY LLC

 

 

By:

 

/s/ W. ANTHONY WILL

Name: W. Anthony Will
Title:
President and Chief Executive Officer

    OCI N.V.

 

 

By:

 

/s/ SALMAN BUTT

Name: Salman Butt
Title:
Chief Financial Officer

    CF B.V.

 

 

By:

 

/s/ DOUGLAS C. BARNARD

Name: Douglas C. Barnard
Title:
Managing Director

    FINCH MERGER COMPANY LLC

 

 

By:

 

/s/ W. ANTHONY WILL

Name: W. Anthony Will
Title:
President and Chief Executive Officer


Exhibit A

21 DECEMBER 2015
UNOFFICIAL ENGLISH TRANSLATION
ARTICLES OF ASSOCIATION
CF N.V.

NOTE ABOUT TRANSLATION:

        This document is an English translation of a document prepared in Dutch. In preparing this document, an attempt has been made to translate as literally as possible without jeopardizing the overall continuity of the text. The definitions in this document are listed in the English alphabetical order which may differ from the Dutch alphabetical order. Inevitably, however, differences may occur in translation and if they do, the Dutch text will govern by law. In this translation, Dutch legal concepts are expressed in English terms and not in their original Dutch terms. The concepts concerned may not be identical to concepts described by the English terms as such terms may be understood under the laws of other jurisdictions.

ARTICLES OF ASSOCIATION

1
1          DEFINITIONS

1.1
In these articles of association:

1


1.2
Unless the context dictates otherwise, in the Articles:

(a)
words and expressions in the singular form also include the plural form and vice versa;

(b)
words and expressions in the masculine form also include the feminine and neuter form; and

(c)
a reference to a statutory provision is a reference to that statutory provision along with all amendments, additions and replacements that may apply from time to time.

2
2          NAME, SEAT AND OBJECTS

2.1
Name and seat

2.1.1
The name of the Company is CF N.V.

2.1.2
Its seat is in Amsterdam, the Netherlands.

2.2
Objects

2.2.1
The objects of the Company are:

(a)
to organise, participate in and manage, all in any way whatsoever, businesses and companies, including without limitation businesses and companies of which the objects are to establish and sustain a foundation in the area of manufacturing, import, export, purchase, sale, distribution and marketing of products and raw materials;

(b)
to acquire or dispose of businesses and companies;

(c)
to acquire or dispose of, and manage and exploit in any way whatsoever, real property and tangible and intangible assets;

(d)
to borrow or otherwise raise funds;

(e)
to lend monies to, or act as surety (or guarantor in any other manner) for the obligations of, and businesses and companies forming part of the Company, its Subsidiaries and third parties;

(f)
to render administrative, technical, financial, economic or managerial services to the businesses and companies forming part of the Company and its Subsidiaries and to third parties;

(g)
to perform any and all other activities of an industrial, financial or commercial nature,

and, whether or not in collaboration with third parties, to perform all other activities which directly and indirectly relate to those objects, all to be interpreted in the broadest sense.

2


3
3          CAPITAL AND ISSUE OF SHARES

3.1
Capital and Shares

3.1.1
The authorised capital of the Company is EUR [     ·     ] and is divided into:

(a)
[     ·     ] ([     ·     ]) ordinary shares, each with a nominal value of one euro cent (EUR 0.01); and

(b)
[     ·     ] ([     ·     ]) cumulative preference shares, each with a nominal value of one euro cent (EUR 0.01).

3.1.2
The Shares are numbered consecutively. Ordinary shares are numbered from 1 onwards and cumulative preference shares are numbered from CP1 onwards.

3.1.3
Shares may be issued in registered form only.

3.1.4
The Company will not cooperate with the issue of depositary receipts for Shares.

3.2
Issue of Shares

3.2.1
Shares are issued pursuant to a resolution proposed by the Board and adopted by the General Meeting, or pursuant to a Board resolution if the General Meeting has resolved to authorise the Board to issue Shares for a specific period not exceeding five years. Unless otherwise stipulated in the authorisation, the authorisation may not be withdrawn.

3.2.2
The General Meeting or the Board, if authorised to issue Shares, shall determine the issue price and the further terms of the issue in its resolution to issue Shares.

3.2.3
Articles 3.2.1 and 3.2.2 equally apply to a grant of rights to subscribe for Shares, but do not apply to an issue of Shares to a person exercising a right to subscribe for Shares.

3.3
Payment on Shares

3.3.1
Ordinary shares may only be issued against payment in full of their nominal value. Cumulative preference shares may be issued against partial payment of their nominal value, provided that at least one-fourth of the nominal value is paid upon issue. The Company may, at its sole discretion, make a call in respect of the unpaid part of the nominal value of cumulative preference shares. Any such call will be made by the Board. The Board will give the holders of the cumulative preference shares immediate notice of such call, and there must be at least thirty days between that notification and the payment deadline.

3.3.2
Payment on Shares must be made in cash if no alternative contribution has been agreed. Payment other than in cash must be made in accordance with the provisions in article 2:94b DCC.

3.3.3
Payment may be made in a non-Dutch currency subject to the Company's consent and in accordance with article 2:80a (3) DCC.

3.3.4
The Board may perform legal acts as referred to in article 2:94 DCC without the prior approval of the General Meeting.

3.4
Pre-emptive right

3.4.1
Subject to the second sentence of this Article 3.4.1 and Article 3.4.2, each holder of ordinary shares has a pre-emptive right with respect to any issue of ordinary shares in proportion to the aggregate amount of that Shareholder's ordinary shares immediately prior to that issue.

3


3.4.2
Pre-emptive rights may be limited or excluded by a resolution proposed by the Board and adopted by the General Meeting.
3.4.3
The resolution of the General Meeting or of the Board, if authorised, determines when adopting a resolution to issue Shares, how and during which period the pre-emptive rights may be exercised.

3.4.4
This Article equally applies to a grant of rights to subscribe for Shares, but does not apply to an issue of Shares to a person exercising a right to subscribe for Shares.

4
OWN SHARES

4.1
Acquisition and disposal of own Shares

4.1.1
The Company may acquire Shares if and to the extent the General Meeting has authorised the Board for this purpose and with due observance of applicable statutory provisions. The authorisation will only be valid for a specific period not exceeding eighteen months.

4.1.2
The authorisation of the General Meeting as referred to in Article 4.1.1 is not required if the Company acquires Shares under a universal title or if the Company repurchases fully paid-up Shares for the purpose of transferring those Shares to employees of the Company or a Group Company under any applicable employee stock purchase plan, provided that those Shares are admitted to an official list of a stock exchange.

4.2
Financial assistance

4.2.1
The Company may not, with the purpose of any other person subscribing for or acquiring Shares, provide security or any price guarantee, act as surety in any other manner, or bind itself jointly and severally or otherwise in addition to or on behalf of others.

4.2.2
The Company may not grant loans with the purpose of subscribing for its Shares or any other person acquiring Shares, unless the Board passes a resolution and the conditions of article 2:98c (2) to (7) inclusive DCC are fulfilled.

4.2.3
Articles 4.2.1 and 4.2.2 do not apply if Shares are subscribed for or acquired by employees of the Company or a Group Company.

4.2.4
Any reference to "Shares" in Articles 4.1.1, 4.2.1 and 4.2.2 includes depositary receipts issued for Shares.

4


4.3
Capital reduction

4.3.1
The General Meeting may resolve on the basis of a proposal of the Board to reduce the issued capital by (i) reducing the nominal value of Shares by amending the Articles, or (ii) cancelling:

(a)
Shares held by the Company itself or for which it holds depositary receipts; or

(b)
all cumulative preference shares.

4.3.2
In the case of cancellation of all cumulative preference shares, the following will be repaid on those cumulative preference shares:

(a)
the amount of nominal value paid-up on those cumulative preference shares;

(b)
the amount of the share premium reserve maintained for the cumulative preference shares; and

(c)
any unpaid dividends on the cumulative preference shares in relation to financial years prior to the financial year in which the cancellation takes place and any dividends accrued on those cumulative preference shares during the financial year in which cancellation takes place, calculated through the day on which the cancellation takes place.

4.3.3
A resolution to reduce the issued capital must state the method of its implementation and the Shares it relates to. Any reduction of the issued capital will be subject to the provisions of articles 2:99 and 2:100 DCC.

5
TRANSFER OF SHARES. CUMULATIVE PREFERENCE SHARES TRANSFER RESTRICTIONS

5.1
Transfer of Shares

5.1.1
The transfer of a Share requires a deed for that purpose and, save in the event that the Company itself is a party to the transaction, the Company's Written acknowledgment of the transfer. Service on the Company of the transfer deed or a certified notarial copy or extract of that deed is regarded as acknowledgment of transfer. The rights attached to Shares may not be exercised until the Company acknowledges the transfer. The Company shall comply with applicable stock exchange regulations in respect of the transfer of Shares.

5.1.2
The preceding paragraph of this Article equally applies to (i) the transfer of a right of usufruct on a Share or (ii) the allotment of Shares or any restricted rights on those Shares in case of any division of any joint interest.

5.2
Cumulative preference shares transfer restrictions

5.2.1
Any transfer of cumulative preference shares will be subject to the provisions of this Article 5.2. This Article 5.2 does not apply to the Company transferring any cumulative preference shares.

5.2.2
Any transfer of cumulative preference shares requires the approval of the Board. The request for approval must made in Writing and must specify the name and the address of the proposed transferee and the price or other consideration which the proposed transferee is willing to pay or give.

5.2.3
The Board will resolve upon the request for approval within three months upon receipt of the request for approval. If the Board fails to resolve upon the request within this period and the transferor has not received from the Company a written notice rejecting the request, the approval of the transfer will be deemed to have been granted.

5


5.2.4
The approval of the transfer will also be deemed to have been granted if the Board has not designated one or several interested buyers who are willing and able to acquire against payment in cash all the cumulative preference shares to which the request for approval relates in the written notice rejecting the request, at a price to be determined in accordance with Article 5.2.5.

5.2.5
The transferor and the designated transferee(s) will determine the price for the cumulative preference shares by mutual agreement. If they have not reached agreement on the price within two months after the date of the written notice of rejection which was combined with the designation of one or several interested buyers to whom the cumulative preference shares concerned may be transferred in accordance with the provisions of this Article, that price will then be determined by an expert to be appointed by the transferor and the Board by mutual agreement. If the Board and the transferor fail to reach such agreement within three months after the notice of rejection, the chairperson of the Royal Notarial Association acting at the request of either of the parties will appoint an expert.

5.2.6
Upon the notification of the price determined by the expert referred to in Article 5.2.5, the transferor may decide to not transfer his cumulative preference shares to the designated transferee, provided he notifies the Board of that decision within one month after he has been informed of the name(s) of the designated interested buyer(s) and of the price determined in the manner as described above.

5.2.7
If approval of the transfer has been granted or is deemed to have been granted, during a period of three months thereafter the transferor will be at liberty to transfer all the cumulative preference shares to which his request for approval related to the transferee proposed in his request for approval and at the price or for the consideration specified in such request for approval.

6
SHAREHOLDERS REGISTER. LIMITED RIGHTS TO SHARES. SHARES HELD IN UNDIVIDED OWNERSHIP

6.1
Shareholders register

6.1.1
The Board shall keep a Shareholders register. The register must be regularly updated. Part of the register may be held abroad to comply with applicable non-Dutch statutory provisions or applicable listing rules.

6.1.2
The name, address and further information as required by law or considered appropriate by the Board will be recorded in the Shareholders register.

6.1.3
The Board shall provide any Shareholder on its request and free of charge with Written evidence of the information in the register concerning the Shares registered in that Shareholder's name. The statement issued may be validly signed on behalf of the Company by a person to be designated for that purpose by the Board.

6.1.4
The provisions in Articles 6.1.2 and 6.1.3 equally apply to holders of a right of usufruct or pledge on one or more Shares, with the exception of a holder of a right of pledge as referred to in article 2:86c (4) DCC.

6.2
Pledge

6.2.1
A right of pledge may be established on Shares.

6.2.2
If an ordinary share is encumbered with a right of pledge, the Shareholder holds the voting rights attached to that Share, unless at the creation of the right of pledge the voting right has been granted to the pledgee.

6


6.2.3
If a cumulative preference share is encumbered with a right of pledge, the voting right may not be granted to the pledgee.

6.2.4
A Shareholder who has no voting rights as a result of a right of pledge and a pledgee with voting rights have Meeting Rights. Pledgees without voting rights have no Meeting Rights.

6.3
Usufruct

6.3.1
A right of usufruct may be established on Shares.

6.3.2
If an ordinary share is encumbered with a right of usufruct, the Shareholder holds the voting rights attached to that Share, unless at the creation of the right of usufruct the voting rights were granted to the holder of the right of usufruct.

6.3.3
If a cumulative preference share is encumbered with a right of usufruct, the voting right may not be granted to the holder of the right of usufruct.

6.3.4
Shareholders who have no voting rights as a result of a right of usufruct and holders of a right of usufruct with voting rights have Meeting Rights. Holders of a right of usufruct without voting rights have no Meeting Rights.

6.4
Shares held in undivided ownership

6.4.1
If one or more Shares or a right of usufruct or right of pledge on one or more Shares are held by more than one person, the Company may decide that the joint owners thereof may only be represented vis-à-vis the Company by one person jointly designated by them in Writing. In the absence of this designation, all rights attaching to the relevant Share(s) will be suspended, except the right to receive dividends and other distributions. The Board may, whether or not subject to certain conditions, grant exemptions from the first sentence of this Article.

7
MANAGEMENT

7.1
Board: composition and duties

7.1.1
The Board conducts the management of the Company.

7.1.2
The Board consists of one or more executive Directors and one or more non-executive Directors, totalling a number of at least three and no more than fifteen Directors.
7.1.3
The Board will appoint one of the non-executive Directors as its Chairman and one of the executive Directors as the CEO. The Board will appoint the Company Secretary, whether or not from among its members.

7.1.4
Directors must duly perform their duties towards the Company and, in doing so, are guided by the interests of the Company and its business.

7.1.5
The executive Directors are responsible for the operational management of the Company and its business and for the implementation of the resolutions adopted by the Board.

7.1.6
The non-executive Directors supervise the policy of and fulfillment of duties by the executive Directors and the general affairs of the Company. The executive Directors shall timely provide the non-executive Directors with any such information as may be necessary for the non-executive Directors to perform their duties.

7


7.2
Board: appointment, suspension and dismissal

7.2.1
Each executive Director and non-executive Director is appointed by the General Meeting at the binding nomination of the Board.

7.2.2
The General Meeting may, for each nomination, resolve to overrule the binding nature of the nomination by a two-thirds majority of votes cast representing more than one-half of the issued capital. If none of the candidates nominated for a position by the Board is appointed, the Board retains the right to make a new binding nomination for such position at a next meeting.

7.2.3
The nomination of a Director must be included in the notice of the General Meeting at which the appointment is considered. If the Board has determined to not to make a binding nomination in respect of a vacancy, the notice must state this and the General Meeting may then appoint a Director without a nomination. If no appointment is made for the vacancy, the Board retains the right to make a binding nomination for such position at a next meeting.

7.2.4
At a General Meeting, votes relating to the appointment of a Director may only be cast for candidates named in the agenda of the meeting or in the explanatory notes to the agenda.

7.2.5
The notice that includes a candidate for appointment as a non-executive Director must state the candidate's age and profession, the number of the Shares held by the candidate, and the positions the candidate holds or has held insofar as they are relevant to the performance of the duties of a non-executive Director. The notice must also state which companies the candidate is already associated with as a non-executive Director or supervisory Director. If they include companies belonging to the same group, an indication of this group will suffice.

7.2.6
Each Director is appointed for a period ending at the close of the next annual General Meeting as referred to in Article 8.1.1. A Director may be reappointed.

7.2.7
A Director may be suspended or removed by the General Meeting at any time by a resolution passed with a majority of votes cast representing more than one-half of the issued and outstanding capital, unless the resolution is adopted upon the proposal of the Board in which case a simple majority of votes cast is sufficient.
7.2.8
If a Director has been suspended, the General Meeting must resolve within three months after the suspension has taken effect whether to dismiss that Director or to lift or extend the suspension. If no such resolution is adopted, the suspension will end. A resolution to extend the suspension may only be adopted once, and the suspension may only be extended for a maximum period of three months, starting on the date of that resolution.
7.2.9
If one or more Directors are unable to act, or in the case of a vacancy or vacancies for one or more Directors, the Board's powers will remain intact, provided that:

(a)
in the event one or more non-executive Directors are unable to act, or in the case of a vacancy or vacancies for one or more non-executive Directors, the remaining non-executive Directors may temporarily appoint a person or persons, as the case may be, to fill such position and perform the tasks of the relevant non-executive Director or non-executive Directors;

(b)
in the event one or more executive Directors are unable to act, or in the case of a vacancy or vacancies for one or more executive Directors, the non-executive Directors may temporarily appoint a person or persons, as the case may be, to fill such position or

8


7.3
Board: decision-making

7.3.1
The Board may adopt Written rules governing, among other things, its decision-making process and working methods, its internal organisation, the composition, duties and organisation of committees, the division of duties among the Directors and any other matters, including matters concerning the Board, the executive Directors, the non-executive Directors, any Board committees, the Chairman and the CEO. The Board Rules may be amended by the Board.

7.3.2
Each Director has a right to cast one vote at Board meetings. Unless the Articles or the Board Rules provide otherwise, all Board resolutions must be adopted by a simple majority of votes cast.

7.3.3
A Director may not participate in the deliberations and decision-making process if that Director has a direct or indirect personal conflict of interest with the Company and its business. If as a result of the previous sentence the Board is unable to adopt a resolution, the resolution may nonetheless be adopted by the Board and the previous sentence of this Article 7.3.3 will not apply.

7.3.4
Subject to the Board Rules, the Board may also adopt resolutions without holding a meeting, provided that the Board Rules permit the Board to do so. Articles 7.3.2 and 7.3.3 equally apply to the adoption of resolutions by the Board without holding a meeting.

7.3.5
The Chairman, or in his absence the Company Secretary, may at any time provide evidence of a Board resolution by way of a Written statement to that effect.

7.4
Board: remuneration

7.4.1
The Company must establish a policy in respect of the remuneration of the Board. The remuneration policy is adopted by the General Meeting upon a proposal of the Board.

7.4.2
The remuneration of the executive Directors and the remuneration of the non-executive Directors is determined by the Board with due observance of the remuneration policy adopted by the General Meeting. The Directors are reimbursed for their expenses.

7.4.3
A proposal with respect to remuneration schemes in the form of Shares or rights to subscribe for Shares must be submitted by the Board to the General Meeting for its approval. This proposal must state at least the maximum number of Shares or rights to subscribe for Shares that may be granted to the Directors and the criteria for making and amending such grants.

9


7.5
Representation

7.5.1
The Board has the power to represent the Company. This power is also vested in each executive Director acting solely.

7.5.2
The Board may grant power of attorney to represent the Company to one or more persons, whether or not employed by the Company, or otherwise authorise them to represent the Company on a continuing basis.

7.6
Indemnity

7.6.1
Unless applicable law provides otherwise, the following will be reimbursed to current and former Directors:

(a)
the reasonable costs of conducting a defence against claims based on acts or failures to act in the exercise of their duties or any other duties currently or previously performed by them at the Company's request;

(b)
any damages or fines payable by them as a result of an act or failure to act as referred to under (a); and

(c)
the reasonable costs of appearing in other legal proceedings in which they are involved as current or former Directors, with the exception of proceedings primarily aimed at pursuing a claim on their own behalf.

7.6.2
There is no entitlement to reimbursement as referred to above if and to the extent that:

(a)
it has been established by a Dutch court that the act or failure to act of the person concerned may be characterised as wilful ( opzettelijk ) or intentionally reckless ( bewust roekeloos ) conduct, unless Dutch law provides otherwise or this would, in view of the circumstances of the case, be unacceptable according to standards of reasonableness and fairness; or

(b)
the costs or financial loss of the person concerned are covered by an insurance and the insurer has paid out the costs or financial loss.

7.6.3
Costs and financial loss will be reimbursed by the Company immediately upon receipt of the invoices or any other document evidencing the costs or financial loss of the person concerned. If and to the extent that it has been established by a Dutch court that the person concerned is not entitled to reimbursement as referred to above, he shall immediately repay the amount reimbursed by the Company.

7.6.4
The person concerned shall follow the Company's instructions relating to the manner of his defence and consult with the Company in advance about the manner of his defence.

7.6.5
Articles 7.6.1 to 7.6.4 inclusive do not affect any rights that the person concerned may have pursuant to any agreement with the Company.

7.6.6
The Company may take out liability insurance for the benefit of the persons concerned.

7.6.7
The Board may implement the above provisions in further detail, in an agreement or otherwise.

8
GENERAL MEETINGS

8.1
Annual General Meeting

8.1.1
An annual General Meeting is held each year within six months after the end of the financial year.

10


8.1.2
The agenda of an annual General Meeting includes in any case the discussion and adoption of the Annual Accounts and the appointment of Directors, and further includes any other business presented by the Board or required pursuant to law or these Articles.

8.2
Extraordinary General Meetings. Information

8.2.1
Other General Meetings will be held when required by law and otherwise as often as the Board deems necessary.

8.2.2
Shareholders may request the Board to convene a General Meeting with due observance of Article 8.3.

8.2.3
The Board will provide to the General Meeting any information it requests, unless this would be contrary to an overriding interest of the Company and its business. If the Board or invokes an overriding interest, the reasons for this must be explained.

8.3
General meeting: place, convocation and agenda

8.3.1
General meetings are held in Amsterdam, Geleen, Haarlemmermeer (Schiphol) or Rotterdam.

8.3.2
One or more Shareholders alone or jointly representing at least the percentage of the issued capital as required by law may, at their request, in accordance with the relevant provisions of law, be authorised by the district court to convene a General Meeting.

8.3.3
Meetings must be convened in accordance with the statutory notice period.

8.3.4
The notice convening a meeting is given by the Board. A General Meeting may be convened by electronic means of communication that is directly and permanently accessible until the meeting.

8.3.5
The Board shall send the notice convening the meeting to the addresses of the Shareholders, pledgees with Meeting Rights and usufructuaries with Meeting Rights shown in the Shareholders register. With the consent of a Shareholder or the pledgee with Meeting Rights or the usufructuary with Meeting Rights, the notice of the meeting may also be given by a legible and reproducible message sent via electronic means of communication to the address provided for those purposes by that Shareholder, pledgee or usufructuary to the Company.

8.3.6
Notices convening a meeting will state:

(a)
the items to be discussed;

(b)
the location, date and time of the General Meeting;

(c)
the procedure for participating and exercising voting rights in the General Meeting through a Written proxy; and

(d)
the procedure for taking part in the General Meeting through electronic means of communication, if this right may be exercised under Article 8.4.3, as well as the Company's website address.

8.3.7
An item requested in Writing by one or more Shareholders solely or jointly representing at least such part of the issued capital as required by law will be included in the notice of the meeting or announced in the same manner if the Company receives the request, including the reasons, no later than on the date prescribed by law.

8.3.8
Notwithstanding the provisions of Article 8.3.7, items for which a request has been filed by one or more Shareholders solely or jointly in accordance with rules established from time to time by the Board will be included by the Board in the notice of a General Meeting.

11


8.4
General Meeting: attending the meeting

8.4.1
A person is entitled to attend a General Meeting if that person:

(a)
is a Shareholder or another Person with Meeting Rights on the twenty-eighth day prior to the day of that General Meeting;

(b)
is registered as such in a register (or one of more parts of a register) designated for that purpose by the Board; and

(c)
has given notice in writing to the Company prior to a date set in the notice to attend a General Meeting.

8.4.2
The notice must contain the name and the number of Shares the person will represent in the meeting. The provision above under (c) concerning the notice to the Company also applies to the proxy holder of the person entitled to attend the General Meeting.

8.4.3
The Board may decide that each person entitled to attend a General Meeting has the right, in person or represented by a Written proxy, to take part in, address and vote at the General Meeting using electronic means of communication, provided that the person can be identified via the same electronic means and is able to directly observe the proceedings and vote at the meeting. The Board may attach conditions to the use of the electronic means of communication, provided that these conditions are reasonable and necessary for the identification of the person attending the General Meeting and for the reliability and security of the communication. The conditions are included in the notice convening the meeting and are published on the Company's website.

8.4.4
Directors are authorised to attend the General Meeting and have an advisory vote in that capacity at the General Meeting.

8.4.5
The chairman of the meeting may admit third parties to the General Meeting.

8.4.6
The chairman of the meeting decides on all matters relating to admission to the General Meeting.

8.5
General Meeting: order of the meeting, minutes

8.5.1
The General Meeting is chaired by the Chairman. However, the Chairman may charge another person with chairing the General Meeting even if the Chairman is present at the meeting. If the Chairman is absent and has not charged another person with chairing the meeting in his place, the Directors present at the meeting appoint one of them as chairman of the meeting. If the chairman of the meeting has not been appointed in accordance with the preceding sentence, the General Meeting will appoint at its discretion a chairman of the meeting. Until that moment, a member of the Board appointed for that purpose by the Board will act as chairman of the meeting.
8.5.2
The chairman of the meeting determines the order of proceedings in accordance with the agenda and may limit speaking time or take other measures to ensure that the meeting proceeds in an orderly manner.

8.5.3
All issues relating to the proceedings at or concerning the meeting are decided by the chairman of the meeting.

8.5.4
The chairman of the meeting shall appoint one of those present to take minutes, which he and the secretary of the meeting shall adopt and, in evidence thereof, sign. If the proceedings at the

12


8.5.5
A Written confirmation signed by the chairman of the meeting and the secretary of the meeting and stating that the General Meeting has adopted a resolution constitutes valid proof of that resolution towards third parties.

8.6
General Meeting: decision-making process

8.6.1
Unless the law provides otherwise, a resolution of the General Meeting can only be validly adopted in a meeting where the quorum applicable to such resolution is present.
8.6.2
Unless these Articles or the law provide otherwise, resolutions of the General Meeting will be adopted by a simple majority of votes cast at a meeting where the quorum applicable to such resolutions is present.

8.6.3
Each Share confers the right to cast one vote at the General Meeting. Blank votes, abstentions and invalid votes are regarded votes that have not been cast. Resolutions may be adopted by acclamation if none of the Persons with Voting Rights present or represented at the meeting objects to voting by acclamation.

8.6.4
No vote may be cast at the General Meeting for a Share held by the Company or one of its Subsidiaries. Holders of a right of usufruct on Shares belonging to the Company or its Subsidiaries are not excluded from voting if the right of usufruct was created before the Share concerned was held by the Company or one of its Subsidiaries and the voting rights were granted to the holder of the right of usufruct when that right of usufruct was created. The Company or a Subsidiary may not cast a vote in respect of a Share on which it holds a right of usufruct.

8.6.5
The chairman of the meeting determines the method of voting.

8.6.6
The ruling by the chairman at the meeting on the outcome of a vote is decisive. The same applies to the content of a resolution adopted, to the extent that a vote was held on a proposal not set out in Writing.

8.6.7
All disputes concerning voting for which neither the law nor the Articles provide are decided by the chairman of the meeting.

8.7
Meetings of holders of ordinary shares

8.7.1
Meetings of holders of ordinary shares will be convened each time such meeting is required to pass a resolution pursuant to law or these Articles, or if the Board so decides.

13


8.7.2
The provisions of Articles 8.3.1, Article 8.3.3 through 8.3.6 and Article 8.4 through 8.6 are applicable mutatis mutandis to a meeting of holders of ordinary shares.

8.8
Meetings of holders of cumulative preference shares

8.8.1
Meetings of holders of cumulative preference shares will be convened each time such meeting is required to pass a resolution pursuant to law or these Articles, or if the Board so decides.

8.8.2
The provisions of Articles 8.3.1, Article 8.3.3 through 8.3.6 and Article 8.4.3 through 8.6 are applicable mutatis mutandis to a meeting of holders of cumulative preference shares, provided that only holders of cumulative preference shares will be entitled to attend that meeting and to cast votes at that meeting.

8.8.3
In a meeting of holders of cumulative preference shares in which the entire share capital issued in the form of cumulative preference shares is represented, valid resolutions may be passed even if the requirements regarding the venue of the meeting, the manner of convening the meeting, the period to be observed for convening the meeting and the requirements regarding stating the items to be discussed at the meeting have not been observed, provided the resolutions are adopted unanimously.

8.8.4
Any resolutions that may be adopted by a meeting of holders of cumulative preference shares may be adopted without a meeting as well. Such resolution will only be valid if all persons who are entitled to vote in a meeting of holders of cumulative preference shares have declared themselves in favour of the proposal in Writing.

8.8.5
All notices, notifications and communications that are solely intended for holders of cumulative preference shares must be sent in writing, by telegraph, fax or by electronic mail to the address of those Shareholders as recorded in the shareholders register.

9
9          ANNUAL REPORTING

9.1
Financial year. Annual Accounts

9.1.1
The Company's financial year coincides with the calendar year.

9.1.2
Each year, within the period prescribed by law, the Board prepares Annual Accounts. The Annual Accounts, consisting of a balance sheet, a profit and loss account, explanatory notes and consolidated accounts, must be accompanied by an auditor's statement as referred to in Article 9.2.4, the management report, as well as the other particulars to be added to those documents by virtue of applicable statutory provisions. The Annual Accounts are signed by all Directors; if the signature of one or more of them is missing, this and the reasons for this must be disclosed.

9.1.3
The Company ensures that the Annual Accounts, the management report and the additional information referred to in Article 9.1.2 are available at the Company's address from the day of the notice of the General Meeting where they are to be discussed. The Persons with Meeting Rights may inspect these documents and obtain a copy free of charge.

9.1.4
The Annual Accounts are adopted by the General Meeting.

9.1.5
In the General Meeting where adoption of the Annual Accounts is discussed, separate proposals may be raised to grant discharge to the Directors for the performance of their duties. This discharge only applies to the performance of duties as reflected by the Annual Accounts or by information otherwise made available to the General Meeting.

14


9.2
Auditor

9.2.1
The General Meeting instructs an auditor, as referred to in article 2:393 (1) DCC, to audit the Annual Accounts prepared by the Board in accordance with article 2:393 (3) DCC.

9.2.2
If the General Meeting fails to issue the instructions to the auditor, the Board is authorised to do so.

9.2.3
The instructions issued to the auditor may be revoked by the General Meeting and by the person issuing the instructions. The instructions may only be revoked for valid reasons and in accordance with article 2:393 (2) DCC.

9.2.4
The auditor reports the findings of the audit to the Board and presents the results of the audit in a statement on the true and fair view provided by the Annual Accounts. The auditor's performance is evaluated annually by the Board, and the outcome of this evaluation is discussed by the Board during the annual General Meeting.

9.2.5
The Board may issue instructions (other than those referred to above) to the above auditor or to a different auditor at the Company's expense.

10
10        PROFIT AND LOSS. DISTRIBUTIONS ON SHARES

10.1
Reserves. Distributable equity

10.1.1
The Board maintains a share premium reserve for each specific class of Shares; only the holders of Shares of that specific class are exclusively entitled to those reserves.

10.1.2
The Company may make distributions on Shares only to the extent that its own funds exceed the sum of the paid-up and called-up portion of the capital, and the statutory reserves.

10.1.3
Distributions from the profits, are made after the adoption of the Annual Accounts that show the distributions are permitted, subject to any other provisions in these Articles.

10.2
Order of distributions on Shares

10.2.1
Out of the profits earned in a financial year, primarily and insofar as possible, a preferred dividend will be paid on each issued cumulative preference share in an amount equal to (i) the average of the Euribor interest charged for loans with a term of twelve months—weighted by the number of days which this interest was applicable to—during the financial year for which the distribution is made plus (ii) a premium to be determined by the Board of at most five hundred basis points, which premium will each time be fixed by the Board for a period of five years, per annum, calculated, through the day the amount is made payable, over:

(a)
an amount equal to the called-up and paid-up part of the nominal value of such cumulative preference share, provided that:

(i)
if in the financial year for which the dividend mentioned above is paid, the amount of called-up and paid-up part of the nominal value of the cumulative preference shares has been reduced or, pursuant to a resolution to make a further call on those cumulative preference shares, has been increased, the dividend will be reduced or, as the case may be, increased by an amount equal to the aforesaid percentage of the amount of such reduction or increase, as the case may be, calculated from the date of the reduction or, as the case may be, from the date when the further call on the Shares was made; and

(ii)
if in the course of any financial year cumulative preference shares have been issued, with respect to that financial year the dividend to be paid on the Shares concerned will

15


10.2.2
The Board determines which portion of any profits remaining after application of Article 10.2.1 will be reserved.

10.2.3
The profit remaining after application of Articles 10.2.1 and 10.2.2 will be at the disposal of the General Meeting, which may resolve to add the profits to the reserve or to distribute it among the holders of ordinary shares. No further distributions will be made on the cumulative preference shares.

10.2.4
Subject to the other provisions in Articles 10.1 and 10.2, the General Meeting may, on the basis of a proposal of the Board, resolve to make distributions to holders of Shares from one or more reserves that the Company is not required to maintain by law and are not connected to another class of Shares.

10.2.5
No distributions are made on Shares held by the Company, unless those Shares are subject to a right of usufruct.

10.3
Dividend policy. Deficit. Non-cash distributions. Payment

10.3.1
The Board may adopt a policy on reserves and dividends.

10.3.2
The Board may determine how a deficit shown by the Annual Accounts is to be dealt with.

10.3.3
Both the Board and the General Meeting, on the basis of a proposal by the Board, may determine that a distribution on Shares is not made in cash but in the form of Shares, or that holders of Shares are given the choice between distribution in cash or in the form of Shares, or a combination of the two, all these distributions being made from the profits or from a reserve or from both. The Board may determine the conditions under which this choice may be made.

10.3.4
Distributions are payable not later than thirty days after the date on which they were declared, unless the corporate body that determines the distribution sets a different date.

10.3.5
Distributions which have not been claimed within five years and one day after they become payable are returned to the Company and added to the reserves.

10.3.6
The Board may determine that distributions on Shares are made payable in euro or another currency, at the Shareholder's discretion.

16


10.4
Interim distributions

10.4.1
The Board may resolve to make interim distributions to Shareholders or holders of Shares of a specific class. This distribution is only allowed if an interim statement of assets and liabilities shows that the requirements of in Article 10.1.2 have been fulfilled.

10.4.2
The interim statement of assets and liabilities relates to the situation on a date no earlier than the first day of the third month before the month in which the resolution to make a distribution is made public. It must be prepared in accordance with the generally acceptable valuation principles. The statement includes the amounts to be reserved under the law and the Articles. It is signed by the Directors. If one or more of their signatures is missing, this and the reason for the missing signature must be stated.

11
SPECIAL RESOLUTIONS. CERTAIN BUSINESS COMBINATIONS.

11.1
Significant change in identity or nature of the Company

11.1.1
The approval of the General Meeting is required for resolutions of the Board regarding a significant change in the identity or nature of the Company or its business, including in any event:

(a)
the transfer of the business, or practically the entire business, to a third party;

(b)
concluding or cancelling a long-lasting cooperation of the Company or a Subsidiary with another legal person or company or as a fully liable general partner in a partnership, provided that the cooperation or cancellation is of essential importance to the Company;

(c)
acquiring or disposing of a participating interest in the capital of a company with a value of at least one-third of the sum of the Company's assets, as shown in the consolidated balance sheet with explanatory notes according to the last adopted Annual Accounts, by the Company or a Subsidiary.

11.1.2
A resolution to grant the approval as referred to under Article 11.1.1 (i) may only be adopted at the proposal of the Board, and (ii) requires a majority of votes cast representing more than one-half of the issued and outstanding capital.

11.2
Certain business combinations

11.2.1
Solely for the purpose of interpretation of this Article 11.2, the following definitions—including cross-references within these definitions—are to be interpreted as follows:

17


18


11.2.2
The approval of the General Meeting is required for a resolution of the Board to engage in any Business Combination with any Interested Shareholder for a period of three years following the time that such Shareholder became an Interested Shareholder, provided that the resolution of the General Meeting must be adopted by a majority of votes cast representing at least two-thirds of the issued capital which is not Owned by the Interested Shareholder.

11.2.3
Article 11.2.2 does not apply if:

(a)
prior to the time that such Shareholder became an Interested Shareholder, the Board approved, with such terms and conditions as the Board deems appropriate, either the

19


12
AMENDMENTS TO THE ARTICLES. DISSOLUTION

12.1
Amendment to the Articles

12.1.1
The General Meeting may resolve to amend the Articles, provided that such resolution (i) may only be adopted at the proposal of the Board, and (ii) requires a majority of votes cast representing more than one-half of the issued and outstanding capital.

12.1.2
When a proposal to amend the Articles is to be made to the General Meeting, the notice convening the General Meeting must state this and a copy of the proposal, including the verbatim text of the proposal, must be filed and made available at the Company's seat, with copies to be retained at other locations as the Board determines, for inspection by the Shareholders, until the conclusion of the meeting. From the day of filing until the day of the meeting, a Shareholder will, on application, be provided with a copy of the proposal free of charge. An amendment of the Articles will be laid down in a notarial deed executed before a notary officiating in a municipality in the Netherlands.

12.2
Liquidation

12.2.1
The General Meeting may resolve to dissolve the Company, provided that such resolution (i) may only be adopted at the proposal of the Board, and (ii) requires a majority of votes cast representing more than one-half of the issued and outstanding capital.

   


(1)
Note to Draft:     Prior to the closing of the combination, the Board shall approve (A) OCI N.V. and the "S Shareholders" (as such term is defined in that certain Amended and Restated Shareholders' Agreement, by and among CF B.V., Capricorn Capital B.V., Leo Capital B.V., Aquarius Investments B.V. and OCI N.V., dated as of December 20, 2015) (the "Shareholders Agreement") and each of OCI N.V.'s and the S Shareholders' respective "Affiliates" and "Associates" as defined in the Shareholders Agreement for purposes of this article, such approval to be subject to the condition that such approval shall only be effective as long as (i) Section 3.1 of the Shareholders Agreement is effective and (ii) such persons are in compliance with the terms of the Shareholders Agreement and (B) any transaction provided for in the Combination Agreement, by and among CF Industries Holdings, Inc., CF B.V., Finch Merger Company LLC and OCI N.V., dated as of August 6, 2015, as amended (the "Combination Agreement") or the Ancillary Agreements (as defined in the Combination Agreement).

20


12.2.2
If the Company is dissolved, the liquidation is carried out by the executive Directors under the supervision of the non-executive Directors, unless the General Meeting resolves otherwise.

12.2.3
The Articles remain in force where possible during the liquidation.

12.2.4
From the balance remaining after payment of the debts of the dissolved Company, there will first, insofar as possible, be paid on each cumulative preference share:

(a)
an amount equal to the paid-up part of the nominal value of that cumulative preference share;

(b)
any missing dividend on a cumulative preference share in relation to financial years prior to the financial year in which such payment is made payable; and

(c)
any dividend accrued on a cumulative preference share during the financial year in which the Company ceases to exist, calculated through the day on which that payment is made payable.

12.2.5
The balance remaining after application of Article 12.2.4 will be paid out on the ordinary shares in proportion to their nominal value.

12.2.6
After the Company has ceased to exist, the Company's accounts, records and other data carriers must be kept for seven years by the person identified for that purpose by the liquidators.

13
13        JURISDICTION

        Unless the Company consents in Writing to the selection of an alternative forum, the competent court of Amsterdam, the Netherlands, shall be the exclusive forum for any dispute between a Shareholder, in its capacity as Shareholder, and (i) the Company or (ii) any Director or person referred to in Article 7.2.9, acting in such capacity.

        Any reference to "Shareholder" in this Article 13 includes a former Shareholder who was a Shareholder at the time this Article was effective, as well as any holder of a right of usufruct on a Share, any holder of a right of pledge on a Share and any holders of rights to acquire Shares, including all such persons who formerly had such capacity at a time this Article was effective.

        Any reference to "Director" or "person referred to in Article 7.2.9" in this Article 13 includes any person who formerly had such capacity.

14
TRANSITIONAL PROVISIONS

14.1
Authorisation to issue Shares and exclude or restrict pre-emptive rights

14.1.1
As of the execution of this deed of amendment of the Articles on [     ·     ] two thousand and [     ·     ] the Board has been authorised for a period of five years, to issue Shares, including ordinary shares and cumulative preference shares, up to the amount of Shares included in the authorised share capital and to grant rights to subscribe for Shares up to the maximum referred to above.

14.1.2
As of the execution of this deed of amendment of the Articles on [     ·     ] two thousand and [     ·     ] the Board has been authorised for a period of five years, to restrict or exclude pre-emptive rights on Shares.

14.1.3
This Article 14 and its heading lapses on [     ·     ] two thousand and [     ·     ].

21


14.2
Authorisation to repurchase Shares

14.2.1
As of the execution of this deed of amendment of the Articles on [     ·     ] two thousand and [     ·     ] the Board has been authorised for a period of eighteen months, to repurchase fully paid-up ordinary shares in its own capital for a maximum of one-half of the issued capital at the moment of repurchase, at a price per ordinary share not lower than one-fourth of the nominal value of the respective ordinary share, and not higher than one hundred ten per cent the most recent closing price of an ordinary share on any stock exchange where ordinary shares in the share capital of the Company are listed;

14.2.2
As of the execution of this deed of amendment of the Articles on [     ·     ] two thousand and [     ·     ] the Board has been authorised for a period of eighteen months, to repurchase fully paid-up cumulative preference shares in its own capital for a maximum of one-half of the issued capital at the moment of repurchase, at a price per cumulative preference shares as would, pursuant to the Articles, be repaid on such cumulative preference shares if such cumulative preference shares were to be cancelled.

14.2.3
This Article 14.2 and its heading lapses on [     ·     ] two thousand and [     ·     ].

14.3
First financial year

14.3.1
The first financial year will end on the thirty-first day of December two thousand and sixteen.

14.3.2
This Article 14.3 and its heading lapses after expiry of the first financial year.

22


Exhibit B

         DATED December 20, 2015
CF B.V.,
CAPRICORN CAPITAL B.V.,
LEO CAPITAL B.V.,
AQUARIUS INVESTMENTS B.V.
AND
OCI N.V.
AMENDED AND RESTATED SHAREHOLDERS' AGREEMENT

1


This Agreement (this " Agreement ") is made on December 20, 2015

BY AND AMONG:

(1)
CF B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 64782573) whose registered office is at Prins Bernhardplein 200, 1097 JB, Amsterdam, The Netherlands (the " Company ");

(2)
OCI N.V. , a public company with limited liability ( naamloze vennootschap ) incorporated under the law of The Netherlands (registered number 56821166) whose registered office is at Honthorststraat 19, 1071 DC Amsterdam, The Netherlands (" Oxford ");

(3)
Capricorn Capital B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 56929870) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Capricorn ");

(4)
Leo Capital B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 56929315) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Leo "); and

(5)
Aquarius Investments B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 56929102) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Aquarius " and, together with Leo and Capricorn, the " S Shareholders " and, together with Oxford, the " Shareholders ").

WHEREAS:

(A)
CF Industries Holdings, Inc., a Delaware corporation (" Cambridge "), the Company, Finch Merger Company LLC, a Delaware limited liability company and wholly-owned, direct or indirect, subsidiary of the Company (" MergerCo "), and Oxford are parties to that certain Combination Agreement, dated as of August 6, 2015, as amended (the " Combination Agreement ");

(B)
Pursuant to the Combination Agreement, among other things: (i) Oxford will contribute to the Company certain equity ownership interests in certain Persons owned, directly or indirectly, by Oxford, in exchange for consideration consisting, in part, of Ordinary Shares (as defined below) to be issued by the Company to Oxford, (ii) a portion of the Ordinary Shares issued by the Company to Oxford will be distributed by Oxford to its shareholders (the " Distribution ") and (iii) MergerCo will merge with and into Cambridge, with Cambridge becoming a wholly-owned, direct or indirect, subsidiary of the Company whereby the shares of Cambridge common stock will be converted into the right to receive a certain ratio of Ordinary Shares upon the terms and conditions set forth in the Combination Agreement; and

(C)
The Company and the Shareholders desire to establish in this Agreement certain terms and conditions concerning the Ordinary Shares to be owned directly or indirectly by the Shareholders as of and after the Closing and related provisions concerning the Shareholders' relationship with and investment in the Company as of and after the Closing.

2


IT IS AGREED as follows:

1.     Interpretation

        In this Agreement:

1.1   Definitions

        " Affiliate " means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, Controls, or is Controlled by, or is under Common Control with, such Person, provided that neither the Shareholders, nor any of their Subsidiaries shall be deemed to be an Affiliate of the Company or vice versa, and provided, further, that solely for purposes of this Agreement, any settlor of a Family Trust shall be deemed to be an Affiliate of such Family Trust;

        " Articles " mean the articles of association of the Company, as amended from time to time in accordance with the provisions of this Agreement;

        " Associate " means, with respect to any Person, (i) any Person of which such Person is an officer, partner or equivalent or is, directly or indirectly, the beneficial owner of ten per cent. (10%) or more of any class of equity securities, (ii) any trust or other estate in which such Person has a substantial beneficial interest or as to which such Person serves as trustee or in a similar fiduciary capacity, and (iii) any Family Member or spouse of such Person;

        " Beneficially Own " means, with respect to any securities, having "beneficial ownership" of such securities for purposes of Rule 13d-3 or 13d-5 under the Exchange Act (as in effect on the date of this Agreement and (ii) having the right to become the Beneficial Owner of such securities (whether such right is exercisable immediately or only after the passage of time or the occurrence of conditions) pursuant to any agreement, arrangement or understanding, or upon the exercise of conversion rights, exchange rights, rights, warrants or options, or otherwise. The terms " Beneficial Owner ", " Beneficial Ownership " and " Beneficially Owned " shall have a correlative meaning;

        " Board " means, as of any date, the board of directors of the Company on such date;

        " Business Day " means a day which is not a Saturday or Sunday or a bank or public holiday in New York, New York or The Netherlands;

        " Capricorn " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of Capricorn are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees;

        " Closing " has the meaning given to such term in the Combination Agreement;

        " Combination Agreement " has the meaning given to such term in the recitals to this Agreement;

        " Competitor " means any Person set forth on Schedule A;

        " Control " (including, with correlative meanings, " Controlled by " and " under Common Control with ") means the possession, direct or indirect, of the power to direct or cause the direction of management or policies of a Person, whether through ownership of securities, by contract or otherwise;

        " Director " means any member of the Board;

        " Directed Offering " means any so-called "registered direct" sale, block trade or other similar offering or Transfer made pursuant to an effective registration statement filed under the Securities Act, but in which the Voting Securities Transferred are not directly or indirectly widely distributed, and the Shareholder making such Transfer has knowledge of the identity of each transferee;

        " Distribution " has the meaning given to such term in the recitals to this Agreement;

3


        " Effective Time " has the meaning given to such term in the Combination Agreement;

        " Exchange Act " means the U.S. Securities Exchange Act of 1934, as amended;

        " Family Member " with respect to any individual, means such individual's mother, father, sisters, brothers and children;

        " Family Trust " means a trust for the benefit of one or more S Family Members;

        " Firewater One Shareholder Agreement " has the meaning given to such term in the Combination Agreement;

        " Group " has the meaning assigned to such term in Section 13(d)(3) of the Exchange Act and Rule 13d-5(b) thereunder;

        " Ordinary Shares " means the ordinary shares of the Company;

        " Organisational Documents " means, with respect to any Person:

        " Other Shares " means shares of any class of share capital of the Company (other than Ordinary Shares) that are entitled to vote on the appointment or removal of Directors;

        " Ownership Limit " means, at any time of determination, twenty point five per cent. (20.5%) of the Voting Securities outstanding at such time, computed without regard to any Oxford Shares;

        " Ownership Threshold " means, at any time of determination, five per cent. (5%) of the Voting Securities outstanding at such time;

        " Oxford " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of Oxford are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees;

        " Oxford Shares " means the Ordinary Shares acquired by Oxford (i) pursuant to the Combination Agreement and not included in the Distribution and (ii) pursuant to the Firewater One Shareholder Agreement, if any;

        " Permitted Transferee " means the Company or any direct or indirect wholly-owned Subsidiary or Controlled Affiliate of any Shareholder, and in the case of Oxford, any shareholder of Oxford who receives Voting Securities pursuant to a pro rata distribution by Oxford after the Effective Time, and in the case of an S Shareholder, (i) an S Family Member, (ii) a Family Trust, or (iii) any direct or indirect wholly-owned Subsidiary or Controlled Affiliate of the foregoing;

4


        " Person " means any individual, private or public company, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organisation, governmental entity or other entity of any kind or nature;

         "Qualified Candidate" means an individual who:

        " Registration Rights Agreements " has the meaning set forth in the Combination Agreement;

        " Representatives " means, with respect to any designated Person, such designated Person's Affiliates and the respective directors, officers, employees, accountants, counsel, consultants and other agents and advisers of such designated Person and its Affiliates;

        " S Family Member " means any of Onsi Naguib Sawiris, his children and remoter issue or the spouses of any of them;

        " SEC " means the United States Securities and Exchange Commission;

        " Securities Act " means the United States Securities Act of 1933, as amended;

        " Shareholder Affiliated Persons " has the meaning given to such term in Clause 5;

        " Shareholder Shares " means Voting Securities Beneficially Owned by the S Shareholders or by Oxford, as the case may be;

        " S Shareholders " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of any S Shareholders are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees;

        " Shareholders " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of any Shareholders are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees, and in the event that Shareholder Shares of any Shareholders are Transferred in accordance with Clause 4.1(c)(v)(A), shall include such transferees;

        " Standstill Period " has the meaning given to such term in Clause 3.1;

        " Subsidiary " has the meaning set forth in the Combination Agreement;

        " Transfer " means any voluntary or involuntary sale, transfer, assignment, pledge, hypothecation, charge, mortgage, license, gift, creation of a security interest in or lien on, grant of any right or option, creation of any convertible, exchangeable or derivative security with respect to, placement in trust (voting or otherwise), encumbrance or other disposition of any kind to any Person, including those by way of hedging or derivative transactions, in each case, directly or indirectly, including by means of a disposition of any equity interests in an S Shareholder or in a Person that directly or indirectly holds any equity interests in an S Shareholder, by operation of law or otherwise, provided , however , that a

5


"Transfer" shall not include any direct or indirect transfer of the equity securities or Control of Oxford. Notwithstanding the foregoing, any direct or indirect mortgage, pledge, hypothecation, encumbrance or any other similar disposition of the nature of a security interest, lien or charge contemplated by the first sentence of this definition, by a Shareholder of any Ordinary Shares, or with respect to any such Ordinary Shares, shall not be deemed to constitute a "Transfer" subject to the restrictions on Transfer contained or referenced herein. The term " Transferred " shall have a correlative meaning; and

        " Voting Securities " means the Ordinary Shares together with any Other Shares.

1.2   Subordinate legislation

        References to a statutory provision include any subordinate legislation made from time to time under that provision.

1.3   Modification etc. of statutes

        References to a statute or statutory provision include that statute or provision as from time to time modified or re-enacted or consolidated.

1.4   Clauses, Schedules etc.

        References to this Agreement include the Schedules to it and this Agreement as from time to time amended and references to Clauses and Schedules are to Clauses of and Schedules to this Agreement, unless the context otherwise require.

1.5   Headings

        Headings shall be ignored in construing this Agreement.

1.6   Parties

        Any reference in this Agreement to a " party " or " parties " shall be a reference to a party or parties to this Agreement.

1.7   Effectiveness of this Agreement

        This Agreement, other than this Clause 1, Clause 2 and Clauses 7 to 9 (which will come into force immediately), will take effect at and as of the Effective Time. Notwithstanding anything to the contrary herein, in the event the Combination Agreement is terminated in accordance with its terms prior to the Effective Time, this Agreement shall terminate immediately and be null and void.

1.8   General interpretation

6


1.9   Actions at the Effective Time

        Upon completion of the Distribution, the S Shareholders shall update Schedule B to reflect all Voting Securities Beneficially Owned by the S Shareholders at such time.

2.     Warranties

2.1   Warranties of the Company

        The Company warrants to the Shareholders as of the date hereof that:

7


2.2   Warranties of the Shareholders

        Each Shareholder warrants, severally, and not jointly, to the Company as of the date hereof that:

8


3.     Standstill; share ownership related information

3.1   Standstill restrictions

        From and after the Effective Time until the one (1) year anniversary of the date on which the S Shareholders, in the aggregate, cease to Beneficially Own Voting Securities representing at least the Ownership Threshold (the " Standstill Period "), each Shareholder agrees that, without the prior written consent of the Board, such Shareholder shall not, and shall cause each of its and their Affiliates and, shall use reasonable endeavours to cause, its and their Representatives acting on their behalf not to, directly or indirectly, alone or acting together with any other Person, except as otherwise (A) expressly set forth in this Clause 3.1 or (B) provided in the Combination Agreement and/or the Firewater One Shareholder Agreement:

9


3.3   Share ownership related information

        For so long as this Agreement is in effect, each Shareholder shall, upon request in writing by the Company, provide to the Company as soon as reasonably practicable and in any event within ten (10) Business Days, any information related to such Shareholder's ownership or holding of Shareholder Shares, including any agreements or arrangements relating to such ownership or holding.

10


4.     Transfer restrictions

4.1   Transfer restrictions

11


12


5.     Freedom to pursue opportunities

        Notwithstanding anything in this Agreement to the contrary, the parties expressly acknowledge and agree that: (a) each Shareholder and its Affiliates (collectively, the " Shareholder Affiliated Persons ") has the right to, and shall have no duty (contractual or otherwise) not to, directly or indirectly engage in the same or similar business activities or lines of business as the Company or any of its Subsidiaries, including those deemed to be competing with the Company or any of its Subsidiaries, and (b) in the event that a Shareholder Affiliated Person acquires knowledge of a potential transaction or matter that may be a corporate opportunity for each of the Company and such Shareholder Affiliated Person, shall have no duty (contractual or otherwise) to communicate or present such corporate opportunity to the Company or any of its Subsidiaries, as the case may be, and shall not be liable to the Company or its Affiliates or shareholders for breach of any duty (contractual or otherwise) by reason of the fact that such Shareholder Affiliated Person, directly or indirectly, pursues or acquires such opportunity for itself, directs such opportunity to another Person, or does not present such opportunity to the Company.

6.     Termination

        This Agreement shall terminate with immediate effect upon the earlier of (a) the date that is one (1) year after the first date on which the S Shareholders, in the aggregate, shall cease to Beneficially Own Voting Securities representing at least the Ownership Threshold; and (b) the date not less than the date five (5) years after the date hereof that the Company elects to terminate this Agreement by giving written notice to the Shareholders; provided that this Clause 6 and Clauses 7 and 8 shall remain in full force and effect following such termination.

7.     Notices

7.1   Addresses

        Any notice or other communication to be given under this Agreement shall be in writing, shall be deemed to have been duly served on, given to or made in relation to a party if it is left at the authorised address of that party, posted by first class mail addressed to that party at such address, or sent by facsimile transmission to a machine situated at such address and shall if:

        For the purposes of this Clause 7 the authorised address of each party shall be the address set out below or such other address (and details) as that party may notify to the others in writing from time to time in accordance with the requirements of this Clause 7:

13


To the Company:

CF B.V.
c/o
CF Industries Holdings, Inc.
4 Parkway North, Suite 400
Deerfield, IL 60015-2590
Telephone: (847) 405-2400
Facsimile: (847) 405-2711
Email: Dbarnard@cfindustries.com
Attention: Douglas C. Barnard
With copies (which shall not constitute notice) to:
Skadden, Arps, Slate, Meagher & Flom LLP
155 North Wacker Drive
Chicago, Illinois 60606
Telephone: (312) 407-0700
Facsimile: (312) 407-0411
Email: brian.duwe@skadden.com, richard.witzel@skadden.com
Attention: Brian W. Duwe, Richard C. Witzel, Jr.
To any of the Shareholders:
Intertrust Netherlands BV
Prins Bernhardplein 200
1097 JB Amsterdam
The Netherlands
Telephone: + 31 20 521 4777
Email: jurjen.hardeveld@intertrustgroup.com
Attention: Jurjen Hardeveld
With copies (which shall not constitute notice) to:
Withers LLP
16 Old Bailey
London EC4M 7EG
United Kingdom
Telephone: +44 (0)20 7597 6116
Email: Samantha.Morgan@withersworldwide.com
Attention: Samantha Morgan
Cleary Gottlieb Steen & Hamilton LLP
One Liberty Plaza
New York, NY 10006
Telephone: (212) 225-2000

14













Facsimile: (212) 225-3999
Email: rdavis@cgsh.com, ptiger@cgsh.com
Attention: Robert P. Davis, Paul M. Tiger
To Oxford:
OCI N.V.
Honthorststraat 19
1071 DC Amsterdam
The Netherlands
Facsimile: +44 (0) 20 7439 4802
Email: Erika.Wakid@oci.nl
Attention: Erika Wakid
With copies (which shall not constitute notice) to:
Cleary Gottlieb Steen & Hamilton LLP
One Liberty Plaza
New York, NY 10006
Telephone: (212) 225-2000
Facsimile: (212) 225-3999
Email: rdavis@cgsh.com, ptiger@cgsh.com
Attention: Robert P. Davis, Paul M. Tiger

8.     General

8.1   Whole agreement

        This Agreement contains the whole agreement between the parties hereto relating to the subject matter hereof at the date hereof to the exclusion of any terms implied by law which may be excluded by contract and supersedes any previous written or oral agreement between the parties in relation to the matters dealt with herein.

8.2   No inducement

        Each party to this Agreement acknowledges that it has not been induced to enter into this Agreement by any representation, warranty or undertaking not expressly provided for in this Agreement.

8.3   Legal advice

        Each party to this Agreement confirms it has received independent legal advice relating to all the matters provided for in this Agreement, including the provisions of this Clause 8.3, and agrees, having considered the terms of this Clause 8.3, and this Agreement as a whole, that the provisions of this Clause 8.3, are fair and reasonable.

15


8.4   Survival of rights, duties and obligations

        Termination of this Agreement for any cause shall not release a party from any liability which at the time of termination has already accrued to another party or which thereafter may accrue in respect of any act or omission prior to such termination.

8.5   Conflict with the Articles

        To the extent permitted by law, in the event of any ambiguity or discrepancy between the provisions of this Agreement and the Articles, it is intended that the provisions of this Agreement shall prevail and accordingly the Shareholders shall exercise all voting and other rights and powers available to them so as to give effect to the provisions of this Agreement and shall further if necessary procure any required amendment to the Articles.

8.6   Several and not joint liability of Shareholders

        Each party hereby agrees that the representations, warranties, covenants and agreements of the Shareholders under this Agreement are being made severally, and not jointly, by the Shareholders, and no Shareholder will be liable for any breach, default, liability or other obligation of any of the other Shareholders.

8.7   No partnership

        Nothing in this Agreement shall be deemed to constitute a partnership between the parties nor constitute any party the agent of any other party for any purpose except as expressly provided in this Agreement.

8.8   Shareholder actions

        Any determination, consent or approval of, or notice or request delivered by, or any other action of, any S Shareholder shall be made by, and shall be valid and binding upon, all S Shareholders, if made by one or more S Shareholders Beneficially Owning a majority of the aggregate amount of the Shareholder Shares Beneficially Owned by the S Shareholders. The Company shall be entitled to demand from time to time and at any time, from the S Shareholders, evidence reasonably satisfactory to the Company of such majority approval before proceeding with the Company's obligations under this Agreement.

8.9   Amendments and waiver

        No amendment, modification or discharge of this Agreement, and no waiver hereunder, shall be valid or binding unless set forth in writing and duly executed by the Company, where enforcement of the amendment, modification, discharge or waiver is sought against the Company; or (ii) each Shareholder, where enforcement of the amendment, modification, discharge or waiver is sought against the Shareholders. Any waiver shall constitute a waiver only with respect to the specific matter described in such writing and shall in no way impair the rights of the party granting such waiver in any other respect or at any other time. The waiver by the Company or the Shareholders of a breach of or a default under any of the provisions of this Agreement or the failure to exercise or delay in exercising any right or privilege hereunder, shall not be construed as a waiver of any other breach or default of a similar nature, or as a waiver of any of such provisions, rights or privileges hereunder. The rights and remedies herein provided are cumulative and none is exclusive of any other, or of any rights or remedies that any party may otherwise have at law or in equity.

16


8.10 Assignment

        This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. Except as contemplated by Clause 4.1(c)(iv), none of the parties may directly or indirectly assign any of their rights or delegate any of their obligations under this Agreement without the prior written consent of the other parties. Any purported direct or indirect assignment in violation of this Clause 8.10 shall be null and void ab initio .

8.11 Further assurance

        At any time after the date of this Agreement the parties shall, and shall use all reasonable endeavours to procure that any necessary third party shall, at the cost of the relevant party execute such documents and do such acts and things as that party may reasonably require for the purpose of giving to that party the full benefit of all the provisions of this Agreement.

8.12 Invalidity

        If any provision in this Agreement shall be held to be illegal, invalid or unenforceable, in whole or in part, under any enactment or rule of law, such provision or part shall to that extent be deemed not to form part of this Agreement but the legality, validity and enforceability of the remainder of this Agreement shall not be affected.

8.13 Counterparts

        This Agreement may be entered into in any number of counterparts, all of which taken together shall constitute one and the same instrument. Any party may enter into this Agreement by signing any such counterpart.

8.14 Costs

        Each party shall bear all costs incurred by it in connection with the preparation, negotiation and entry into this Agreement and the documents to be entered into pursuant to it.

9.     Governing law and submission to jurisdiction

9.1   Governing law

        This agreement and any non-contractual obligation arising out of or in connection with it are governed exclusively by Dutch law, without regard to the conflict of laws thereof.

9.2   Jurisdiction

        All disputes arising out of or in connection with this agreement, including disputes concerning its existence, its validity and any non-contractual obligation, will be resolved by the courts in Amsterdam, the Netherlands.

17


In witness whereof this Agreement has been duly executed.

Signed for and on behalf of CF B.V. by:

/s/ DOUGLAS C. BARNARD

   
Name   Douglas C. Barnard    
Title   Managing Director    

18


Signed for and on behalf of OCI N.V. by:

/s/ SALMAN BUTT

   
Name   Salman Butt    
Title   Chief Financial Officer    

19


Signed for and on behalf of Leo Capital B.V. by:

/s/ G.A.R. WARRIS

   
Name   G.A.R. Warris    
Title   Proxyholder    

Signed for and on behalf of Leo Capital B.V. by:

/s/ P. OOSTHOEK

   
Name   P. Oosthoek    
Title   Proxyholder    

20


Signed for and on behalf of Capricorn Capital B.V. by:

/s/ G.A.R. WARRIS

   
Name   G.A.R. Warris    
Title   Proxyholder    

Signed for and on behalf of Capricorn Capital B.V. by:

/s/ P. OOSTHOEK

   
Name   P. Oosthoek    
Title   Proxyholder    

21


Signed for and on behalf of Aquarius Investments B.V. by:

/s/ G.A.R. WARRIS

   
Name   G.A.R. Warris    
Title   Proxyholder    

Signed for and on behalf of Aquarius Investments B.V. by:

/s/ P. OOSTHOEK

   
Name   P. Oosthoek    
Title   Proxyholder    

22



Schedule A

The Mosaic Company
OJSC "Phosagro"
BASF SE
LyondellBasell Industries N.V.
Honeywell International Inc.
Fertilizantes Heringer S.A.
Grupo Fertipar LTDA
PJSC Uralkali
Glencore plc
Archer-Daniels-Midland Company
HELM AG
Ameropa AG
Keytrade AG
Marubeni Corporation
Saudi Arabian Fertilizer Company / Saudi Basic Industries Corporation
Yara International ASA
Potash Corporation of Saskatchewan Inc.
Qatar Fertiliser Company S.A.Q
PT Pupuk Indonesia (Persero)
Koch Industries, Inc.
OCI N.V.
Agrium Inc.
PETRONAS Chemicals Group Berhard
PetroChina Company Limited
Trammo Inc.
TogliattiAzot Corporation
Borealis AG
Sinofert Holdings Limited
Group DF Limited
EuroChem Group AG
China BlueChemical Ltd.
JSC Acron
Hubei Yihua Fertilizer Co., Ltd.
Indian Farmers Fertiliser Cooperative Limited
Methanol Holdings (Trinidad) Limited

23



Schedule B

S Shareholder Oxford Shares:    
Capricorn Capital B.V.    60,672,376
Leo Capital B.V.    36,491,859
Aquarius Investments B.V.    11,522,425

Oxford Shares held by Affiliates of the S Shareholders:
Onsi Sawiris   51
Nassef Sawiris   68,000
NNS Holding   1,105,723
OS Holding   25,000

OCI N.V. 3.875 per cent. Convertible Bonds due 2018:
NNS Holding   €53,300,000

24


Exhibit C

REGISTRATION RIGHTS AGREEMENT
BETWEEN
CF B.V.
AND
OCI N.V.
DATED AS OF [    
·     ], 2016

1



TABLE OF CONTENTS

 
   
  Page  

ARTICLE I DEFINITIONS

    3  

SECTION 1.1

 

Definitions

   
3
 

SECTION 1.2

 

Other Definitional Provisions

    7  

ARTICLE II Representations and Warranties

   
7
 

SECTION 2.1

 

Representations and Warranties of the Company

   
7
 

SECTION 2.2

 

Representations and Warranties of the Shareholder

    8  

ARTICLE III REGISTRATION RIGHTS

   
8
 

SECTION 3.1

 

Demand Request

   
8
 

SECTION 3.2

 

Piggyback Registration

    10  

SECTION 3.3

 

Shelf Registration

    11  

SECTION 3.4

 

Termination of Registration Obligation

    12  

SECTION 3.5

 

Suspension

    13  

SECTION 3.6

 

Registration Procedures

    13  

SECTION 3.7

 

Registration Expenses

    17  

SECTION 3.8

 

Indemnification; Contribution

    18  

SECTION 3.9

 

Indemnification Procedures

    20  

SECTION 3.10

 

Rule 144; Regulation S

    21  

SECTION 3.11

 

Holdback

    21  

SECTION 3.12

 

Existing Registration Statements

    21  

ARTICLE IV MISCELLANEOUS

   
22
 

SECTION 4.1

 

Injunctive Relief

   
22
 

SECTION 4.2

 

Assignments

    22  

SECTION 4.3

 

Amendments; Waiver

    22  

SECTION 4.4

 

Notices

    22  

SECTION 4.5

 

Governing Law; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury

    23  

SECTION 4.6

 

Interpretation

    23  

SECTION 4.7

 

Entire Agreement; No Other Representations

    24  

SECTION 4.8

 

No Third-Party Beneficiaries

    24  

SECTION 4.9

 

Severability

    24  

SECTION 4.10

 

Counterparts

    24  

SECTION 4.11

 

Further Assurances

    24  

2


        REGISTRATION RIGHTS AGREEMENT, dated as of [     ·     ], 2016 (this " Agreement "), between CF B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated under the law of the Netherlands, which will convert into a public company with limited liability ( naamloze vennootschap ) in accordance with the provisions of the Combination Agreement (as defined herein) (the " Company "), and OCI N.V., a public company with limited liability ( naamloze vennootschap ) incorporated under the law of the Netherlands (" Oxford " or the " Shareholder ").


W I T N E S S E T H:

        WHEREAS, CF Industries Holdings, Inc., a Delaware corporation (" Cambridge "), the Company, Finch Merger Company LLC, a Delaware limited liability company and wholly-owned, direct or indirect, subsidiary of the Company (" MergerCo " and, together with Cambridge and the Company, the " Cambridge Parties "), and Oxford are parties to a Combination Agreement, dated as of August 6, 2015, as amended from time to time prior to the date hereof (the " Combination Agreement "), pursuant to which, among other things, (i) Oxford will convey to the Cambridge Parties, and the Cambridge Parties will acquire from Oxford, certain equity ownership interests in certain Persons owned, directly or indirectly, in their entirety by Oxford in exchange for consideration consisting, in whole or in part, of Ordinary Shares (as defined below) to be issued by the Company to Oxford and (ii) MergerCo will merge with and into Cambridge, with Cambridge becoming a wholly-owned, direct or indirect, subsidiary of the Company (the " Transaction "), upon the terms and conditions set forth in the Combination Agreement; and

        WHEREAS, in connection with the execution and delivery of the Combination Agreement and the consummation of the Transaction, the Company has agreed to grant the Shareholder certain registration rights as set forth below.

        NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, the parties hereto agree as follows:

ARTICLE I

DEFINITIONS

         SECTION 1.1     Definitions.     As used in this Agreement:

3


4


5


6


         SECTION 1.2     Other Definitional Provisions.     Except as expressly set forth in this Agreement or unless the express context otherwise requires:

ARTICLE II

REPRESENTATIONS AND WARRANTIES

         SECTION 2.1     Representations and Warranties of the Company.     The Company represents and warrants to the Shareholders as of the date hereof that:

7


         SECTION 2.2     Representations and Warranties of the Shareholder.     The Shareholder represents and warrants to the Company as of the date hereof as follows:

ARTICLE III

REGISTRATION RIGHTS

         SECTION 3.1     Demand Request .    

8


9


         SECTION 3.2     Piggyback Registration .    

10


         SECTION 3.3     Shelf Registration .    

11


         SECTION 3.4     Termination of Registration Obligation.     Notwithstanding anything to the contrary herein, the obligation of the Company to register Registrable Shares pursuant to this Article III and maintain the effectiveness of any Required Shelf Registration Statement or any Demand Registration Statement filed pursuant to Section 3.1 shall terminate on the first date on which the Shareholder (i) holds Registrable Shares representing less than one percent (1%) of the outstanding Voting Securities and (ii) is able to freely sell its remaining Registrable Shares under Rule 144 under the Securities Act without regard to the volume, manner of sale or filing requirements of such rule (the " Registration Rights Termination Date "); provided , however , the obligation of the Company to register Registrable Shares pursuant to this Article III and maintain the effectiveness of any Required Shelf Registration Statement or any Demand Registration Statement filed pursuant to Section 3.1 shall thereafter revive (the " Revival ") on the date on which the Shareholder receives Registrable Shares as a result of the Company's exercise of its call option pursuant to the terms of the Firewater One Shareholder Agreement if on such date the Shareholder either (i) as a result of the receipt of such

12


Registrable Shares, holds Registrable Shares representing one percent (1%) or more of the outstanding Voting Securities or (ii) holds Registrable Shares representing less than one percent (1%) of the outstanding Voting Securities and is not then able to freely sell its Registrable Shares under Rule 144 under the Securities Act without regard to the volume, manner of sale and filing requirements of such rule. The Revival, if it occurs, shall be effective on the seventh business day following the Company's receipt of notice from the Shareholder of the Revival, which notice must include evidence reasonably satisfactory to the Company of the Shareholder's ownership of a number of Registrable Shares sufficient to give rise to the Revival and, in the case of a Revival under clause (ii) of the immediately-preceding sentence, of the basis for the Shareholder's inability to freely sell its Registrable Shares under Rule 144 under the Securities Act unless it is the same basis that exists at the time this Agreement becomes effective pursuant to Section 4.12. Notwithstanding anything to the contrary in this Agreement, if the Revival becomes effective pursuant to this Section 3.4, the Shareholder shall be entitled to initiate one Demand Registration and one Shelf Registration.

         SECTION 3.5     Suspension.     If the filing, initial effectiveness or continued use of a Registration Statement with respect to a Demand Registration or a Shelf Registration would require the Company to make a public disclosure of material non-public information, which disclosure the Company determines in good faith (after consultation with external legal counsel) would materially impact the Company or would materially impede, delay or interfere with the Company's ability to effect a reasonably imminent material proposed acquisition, disposition, financing, reorganization, recapitalization or similar transaction, then the Company may, upon giving prompt written notice of such determination to the Shareholder, delay the filing or initial effectiveness of, or suspend the use of, as applicable, such Registration Statement or any Prospectus or Free Writing Prospectus; provided , however , that, unless otherwise approved in writing by the Shareholder, the Company shall not be permitted to do so for a period of time in excess of ninety (90) days in the case of any single delay or suspension, and the number of days in any 12-month period on which such a suspension is in effect shall not exceed one hundred twenty (120) (except that such number of days shall not exceed ninety (90) in the 12-month period commencing on the Closing Date (as defined in the Combination Agreement)). In the event that the Company exercises its rights under the preceding sentence, the Shareholder shall suspend, promptly upon receipt of the notice referred to above, the use of any Prospectus or Free Writing Prospectus relating to such Demand Registration or Shelf Registration in connection with any sale or offer to sell Registrable Shares. In the event of such a suspension for which notice is given by the Company after the effectiveness of the applicable Registration Statement, the period specified in clause (A) in Section 3.6(b) (or, in the case of a Required Shelf Registration Statement, the Shelf Period) shall be extended by the number of days of such suspension. The Shareholder shall keep confidential the receipt of any notice under this Section 3.5 and the contents thereof, except as required pursuant to applicable law, and, during any period of such delay or suspension, shall not offer or sell or otherwise transfer any Shareholder Shares or otherwise engage in trading of securities of the Company. Notwithstanding anything to the contrary, upon the commencement of any Scheduled Black-Out Period, the Shareholder shall immediately suspend the use of any Prospectus or Free Writing Prospectus in connection with any sale or offer to sell Registrable Shares until the termination of such Scheduled Black-Out Period.

         SECTION 3.6     Registration Procedures.     Subject to Section 3.5 and the Company's right to withdraw or terminate an applicable Piggyback Registration under Section 3.2(a), whenever the Shareholder shall have requested in accordance with Section 3.1, Section 3.2 or Section 3.3, as applicable, that any Registrable Shares be registered pursuant to Section 3.1, Section 3.2 or Section 3.3, as applicable, the Company shall:

13


14


15


        Subject to the limitations on the Company's ability to delay the filing or initial effectiveness of, or suspend the use of, as applicable, a Registration Statement or a Prospectus or Free Writing Prospectus pursuant to Section 3.5, the Shareholder shall, upon receipt of any written notice from the Company of the happening of any event of the kind described in Section 3.6(f), promptly discontinue its disposition of Registrable Shares pursuant to any Registration Statement until the Shareholder's receipt of the copies of the supplemented or amended prospectus contemplated by Section 3.6(f). If so directed by the Company, the Shareholder shall deliver to the Company (at the Company's expense) all copies, other than permanent file copies, in the Shareholder's possession of the Prospectus covering such Registrable Shares at the time of receipt of such notice. In the event that the Company shall give any such notice, the period specified in clause (A) in Section 3.6(b) (or, in the case of a Required Shelf Registration Statement, the Shelf Period), as applicable, shall be extended by the number of days during the period from and including the date of the giving of such notice to and including the date when the Shareholder shall have been given the copies of the supplemented or amended Prospectus contemplated by Section 3.6(f).

        In the case of any underwritten offering of Registrable Shares registered under a Required Shelf Registration Statement or a Demand Registration Statement filed pursuant to Section 3.1(a), or in the case of a Piggyback Registration under Section 3.2 or a Shelf Registration, (i) all Registrable Shares or Similar Securities to be included in such offering or registration, as the case may be, shall be subject to the applicable underwriting agreement with customary terms (including customary provisions relating to indemnities and contribution), and neither the Shareholder nor any holder of Similar Securities may participate in such offering or registration unless such Person agrees to sell such Person's securities on the basis provided therein; and (ii) neither the Shareholder nor any holder of Similar Securities may participate in such offering or registration unless such Person completes and executes all questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements, custody agreements and other documents reasonably required to be executed in connection therewith, and provides such other information to the Company and the underwriter(s) as may be reasonably requested to offer or register such Person's Registrable Shares or Similar Securities, as the case may be; provided , however , that (A) the Shareholder shall not be required to make any representations or

16


warranties other than those related to title and ownership of, and power and authority to transfer, the Registrable Shares of the Shareholder included therein and the Shareholder's intended method of distribution of such Registrable Shares and as to the accuracy and completeness of statements made in the applicable Registration Statement, Prospectus or other document in reliance upon, and in conformity with, written information prepared and furnished to the Company or the managing underwriter(s) by the Shareholder or its Representatives pertaining to the Shareholder and (B) the aggregate amount of liability of the Shareholder pursuant to any indemnification obligation thereunder shall not exceed the net proceeds received by the Shareholder from such offering. As a condition to including Registrable Shares in any Registration Statement filed in accordance with this Article III , the Company may require that it shall have received an undertaking reasonably satisfactory to the Company from any underwriter to indemnify and hold harmless the Company and its directors, officers and Affiliates to the extent customarily provided by underwriters in connection with similar securities and offerings.

        After the Shareholder has been notified of its opportunity to include Registrable Shares in any Piggyback Registration, the Shareholder (i) shall treat the Offering Confidential Information as confidential information, (ii) shall not use any Offering Confidential Information for any purpose other than to evaluate whether to include its Registrable Shares in such Piggyback Registration and (iii) shall not disclose any Offering Confidential Information to any Person other than such of its Representatives as have a need to know such Offering Confidential Information in connection with such purpose, which Representatives the Shareholder shall cause to comply with the requirements of this paragraph; provided , however , that the Shareholder may disclose Offering Confidential Information if such disclosure is required by legal process, but the Shareholder shall cooperate with the Company to limit the extent of such disclosure through protective order or otherwise, and to seek confidential treatment of the Offering Confidential Information. The Shareholder shall not offer or sell or otherwise transfer any Shareholder Shares or otherwise engage in trading of securities of the Company while in possession of Offering Confidential Information.

         SECTION 3.7     Registration Expenses .    

17


         SECTION 3.8     Indemnification; Contribution .    

18


19


         SECTION 3.9     Indemnification Procedures .    

20


         SECTION 3.10     Rule 144; Regulation S.     The Company will use its reasonable efforts to timely file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder, and to take such further action as the Shareholder may reasonably request, all to the extent required from time to time to enable the Shareholder to sell Registrable Shares without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 or Regulation S under the Securities Act or (ii) any similar rule or regulation hereafter adopted by the SEC.

         SECTION 3.11     Holdback.     The Company and the Shareholder agree, in connection with any underwritten offering of equity securities of the Company, upon the written request of the managing underwriter(s) of such offering, not to effect (other than pursuant to such underwritten offering) any public sale or distribution of Shareholder Shares or other equity securities of the Company, including any sale or distribution pursuant to Rule 144 or Rule 144A under the Securities Act, or make any short sale of, loan, grant any option for the purchase of, or otherwise transfer, any Registrable Shares or other equity securities of the Company, in each case during the Holdback Period (and, if (A) during the last seventeen (17) days of the Holdback Period, the Company issues an earnings release or material news or a material event relating to the Company occurs or (B) prior to the expiration of the Holdback Period, the Company announces that it will release earnings results during the sixteen (16) day period beginning on the last day of the Holdback Period, until the expiration of the eighteen (18) day period beginning on the issuance of the earnings release or the announcement of the material news or the occurrence of the material event), without the prior written consent of the managing underwriter(s). The foregoing sentence shall not apply to the Company in connection with (a) any sale, distribution or transfer of equity securities pursuant to a Special Registration, (b) the issuance by the Company of equity securities upon the exercise of an option or warrant or the conversion of a security, (c) the grant or award of any equity securities pursuant to employee benefit or compensation plans of the Company or (d) any equity securities issued or granted pursuant to any nonemployee director benefit or compensation plan or dividend reinvestment plan or share purchase plan.

         SECTION 3.12     Existing Registration Statements.     Notwithstanding anything to the contrary and subject to applicable law and regulation, the Company may satisfy any obligation hereunder to file or use reasonable efforts to file a Registration Statement or to have a Registration Statement become effective by designating, by notice to the Shareholder, a Registration Statement that previously has been filed with the SEC or become effective, as the case may be, as the relevant Registration Statement for purposes of satisfying such obligation, and all references to any such obligation shall be construed accordingly; provided that such previously filed Registration Statement may be amended or, subject to applicable securities laws, supplemented to add the number of Registrable Shares, and, to the extent necessary, to identify selling securityholders thereunder. To the extent this Agreement refers to the filing or effectiveness of other Registration Statements by or at a specified time and the Company has, in lieu of then filing such Registration Statements or having such Registration Statements become effective, designated a previously filed or effective Registration Statement as the relevant Registration Statement for such purposes, in accordance with the preceding sentence, such references shall be construed to refer to such designated Registration Statement, as amended.

21


ARTICLE IV

MISCELLANEOUS

         SECTION 4.1     Injunctive Relief.     Each party hereto acknowledges that it would be impossible to determine the amount of damages that would result from any breach of any of the provisions of this Agreement and that the remedy at law for any breach, or threatened breach, of any of such provisions would likely be inadequate and, accordingly, agrees that the other parties shall, in addition to any other rights or remedies which they may have, be entitled to such equitable and injunctive relief as may be available from any court of competent jurisdiction to compel specific performance of, or restrain any party from violating, any of such provisions. In connection with any action or proceeding for injunctive relief, each party hereto hereby waives the claim or defense that a remedy at law alone is adequate and agrees, to the maximum extent permitted by law, to have each provision of this Agreement specifically enforced against it, without the necessity of posting bond or other security against it, and consents to the entry of injunctive relief against it enjoining or restraining any breach or threatened breach of such provisions of this Agreement.

         SECTION 4.2     Assignments.     This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. None of the parties may directly or indirectly assign any of their rights or delegate any of their obligations under this Agreement without the prior written consent of the other parties. Any purported direct or indirect assignment in violation of this Section 4.2 shall be null and void ab initio.

         SECTION 4.3     Amendments; Waiver.     No amendment, modification or discharge of this Agreement, and no waiver hereunder, shall be valid or binding unless set forth in writing and duly executed by (i) the Company, where enforcement of the amendment, modification, discharge or waiver is sought against the Company; or (ii) the Shareholder, where enforcement of the amendment, modification, discharge or waiver is sought against the Shareholder. Any such waiver shall constitute a waiver only with respect to the specific matter described in such writing and shall in no way impair the rights of the party granting such waiver in any other respect or at any other time. The waiver by the Company or the Shareholder of a breach of or a default under any of the provisions of this Agreement or the failure to exercise or delay in exercising any right or privilege hereunder, shall not be construed as a waiver of any other breach or default of a similar nature, or as a waiver of any of such provisions, rights or privileges hereunder. The rights and remedies herein provided are cumulative and none is exclusive of any other, or of any rights or remedies that any party may otherwise have at law or in equity.

         SECTION 4.4     Notices.     Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in writing and shall be deemed given to a party when (i) delivered to the appropriate address by hand or by nationally recognized overnight courier service; (ii) sent by facsimile with confirmation of transmission by the transmitting equipment; or (iii) sent by electronic mail (with return receipt received), in each case, to the following addresses, electronic mail addresses or facsimile numbers and marked to the attention of the person (by name or title) designated below, or to such other persons or addresses as may be designated in writing by the party to receive such notice as provided below:

22


         SECTION 4.5     Governing Law; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury.     THIS AGREEMENT AND ANY DISPUTE ARISING OUT OF OR IN CONNECTION WITH IT OR ITS SUBJECT MATTER OR FORMATION INCLUDING NON-CONTRACTUAL DISPUTES OR CLAIMS SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. Each party hereto irrevocably agrees that the state and federal courts located in the state of New York are to have exclusive jurisdiction to settle any dispute arising out of or in connection with this Agreement and, for such purposes, irrevocably submits to the exclusive jurisdiction of such courts. Any proceeding, suit or action arising out of or in connection with this Agreement (" Proceedings ") shall therefore be brought exclusively in any state federal court located in the state of New York. Solely in connection with claims arising under this Agreement or the transactions that are the subject of this Agreement, each party irrevocably (i) waives any objection to Proceedings in such courts on the grounds of venue or on the grounds of forum non conveniens and (ii) agrees that service of process upon such party in any such Proceeding shall be effective if notice is given in accordance with Section 4.4. EACH PARTY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

         SECTION 4.6     Interpretation.     The table of contents and headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions hereof. The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event that an ambiguity or question of intent or interpretation

23


arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement. In the event of any conflict or inconsistency between the provisions of this Agreement and the articles of association of the Company, the terms of this Agreement shall prevail.

         SECTION 4.7     Entire Agreement; No Other Representations.     This Agreement constitutes the entire agreement, and supersedes all prior agreements, understandings representations and warranties both written and oral, between the parties with respect to the subject matter hereof.

         SECTION 4.8     No Third-Party Beneficiaries.     Except as explicitly provided for in Section 3.8 and Section 3.9, this Agreement is not intended to confer upon any Person other than the parties hereto any rights or remedies hereunder.

         SECTION 4.9     Severability.     The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application thereof to any Person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision; and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction.

         SECTION 4.10     Counterparts.     This Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement.

         SECTION 4.11     Further Assurances.     Upon the terms and subject to the conditions set forth in this Agreement, from and after the Effective Date, the parties hereto shall each use reasonable efforts to promptly (i) take, or to cause to be taken, all actions, and to do, or to cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable under applicable law or otherwise to consummate and make effective the transactions contemplated by this Agreement; (ii) obtain from any governmental or regulatory authority or third party any and all necessary clearances, waivers, consents, authorizations, approvals, permits or orders required to be obtained in connection with the performance of this Agreement and the consummation of the transactions contemplated hereby; and (iii) execute and deliver any additional instruments necessary to consummate the transactions contemplated by this Agreement.

[The reminder of this page is intentionally left blank.]

24


        IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the date first written above.

    CF B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

25


    OCI N.V.

 

 

Name:

 




 

 

Title:

 



   

[ Signature Page to Registration Rights Agreement ]

26


Exhibit D

REGISTRATION RIGHTS AGREEMENT
AMONG
CF B.V.
CAPRICORN CAPITAL B.V.
LEO CAPITAL B.V.
AND
AQUARIUS INVESTMENTS B.V.
DATED AS OF [    
·     ], 2016

1



TABLE OF CONTENTS

 
   
  Page

ARTICLE I DEFINITIONS

  3

SECTION 1.1

 

Definitions

 
3

SECTION 1.2

 

Other Definitional Provisions

  7


ARTICLE II Representations and Warranties


 

8

SECTION 2.1

 

Representations and Warranties of the Company

 
8

SECTION 2.2

 

Representations and Warranties of the Shareholders

  8


ARTICLE III REGISTRATION RIGHTS


 

9

SECTION 3.1

 

Demand Request

 
9

SECTION 3.2

 

Piggyback Registration

  11

SECTION 3.3

 

Shelf Registration

  12

SECTION 3.4

 

Termination of Registration Obligation

  13

SECTION 3.5

 

Suspension

  14

SECTION 3.6

 

Registration Procedures

  14

SECTION 3.7

 

Registration Expenses

  18

SECTION 3.8

 

Indemnification; Contribution

  19

SECTION 3.9

 

Indemnification Procedures

  21

SECTION 3.10

 

Rule 144; Regulation S

  22

SECTION 3.11

 

Holdback

  22

SECTION 3.12

 

Existing Registration Statements

  22


ARTICLE IV MISCELLANEOUS


 

23

SECTION 4.1

 

Shareholder Actions

 
23

SECTION 4.2

 

Joint and Several Liability

  23

SECTION 4.3

 

Injunctive Relief

  23

SECTION 4.4

 

Assignments

  23

SECTION 4.5

 

Amendments; Waiver

  23

SECTION 4.6

 

Notices

  23

SECTION 4.7

 

Governing Law; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury

  25

SECTION 4.8

 

Interpretation

  25

SECTION 4.9

 

Entire Agreement; No Other Representations

  25

SECTION 4.10

 

No Third-Party Beneficiaries

  25

SECTION 4.11

 

Severability

  25

SECTION 4.12

 

Counterparts

  25

SECTION 4.13

 

Further Assurances

  25

2


        REGISTRATION RIGHTS AGREEMENT, dated as of [     ·     ], 2016 (this " Agreement "), among CF B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated under the law of the Netherlands, which will convert into a public company with limited liability ( naamloze vennootschap ) in accordance with the provisions of the Combination Agreement (as defined herein) (the " Company "), Capricorn Capital B.V., a private limited liability company incorporated under the law of the Netherlands (" Capricorn "), Leo Capital B.V., a private limited liability company incorporated under the law of the Netherlands (" Leo "), and Aquarius Investments B.V., a private limited liability company incorporated under the law of the Netherlands (" Aquarius " and, together with Capricorn and Leo, the " Shareholders ").


W I T N E S S E T H:

        WHEREAS, CF Industries Holdings, Inc., a Delaware corporation (" Cambridge "), the Company, Finch Merger Company LLC, a Delaware limited liability company and wholly-owned, direct or indirect, subsidiary of the Company (" MergerCo " and, together with Cambridge and the Company, the " Cambridge Parties "), and OCI N.V., a public company with limited liability ( naamloze vennootschap ) incorporated under the law of the Netherlands (" Oxford "), are parties to a Combination Agreement, dated as of August 6, 2015, as amended from time to time prior to the date hereof (the " Combination Agreement "), pursuant to which, among other things, (i) Oxford will convey to the Cambridge Parties, and the Cambridge Parties will acquire from Oxford, certain equity ownership interests in certain Persons owned, directly or indirectly, in their entirety by Oxford in exchange for consideration consisting, in whole or in part, of Ordinary Shares (as defined below) to be issued by the Company to Oxford and (ii) MergerCo will merge with and into Cambridge, with Cambridge becoming a wholly-owned, direct or indirect, subsidiary of the Company (the " Transaction "), upon the terms and conditions set forth in the Combination Agreement;

        WHEREAS, pursuant to the Combination Agreement, the Shareholders will acquire Ordinary Shares; and

        WHEREAS, in connection with the execution and delivery of the Combination Agreement and the consummation of the Transaction, the Company has agreed to grant the Shareholders certain registration rights as set forth below.

        NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, the parties hereto agree as follows:

ARTICLE I
DEFINITIONS

         SECTION 1.1     Definitions.     As used in this Agreement:

3


4


5


6


         SECTION 1.2     Other Definitional Provisions.     Except as expressly set forth in this Agreement or unless the express context otherwise requires:

7


ARTICLE II
REPRESENTATIONS AND WARRANTIES

         SECTION 2.1     Representations and Warranties of the Company.     The Company represents and warrants to the Shareholders as of the date hereof that:

         SECTION 2.2     Representations and Warranties of the Shareholders.     Each Shareholder represents and warrants, jointly and severally, to the Company as of the date hereof that:

8


ARTICLE III
REGISTRATION RIGHTS

         SECTION 3.1     Demand Request .    

9


10


         SECTION 3.2     Piggyback Registration .    

11


         SECTION 3.3     Shelf Registration .    

12


         SECTION 3.4     Termination of Registration Obligation.     Notwithstanding anything to the contrary herein, the obligation of the Company to register Registrable Shares pursuant to this Article III and maintain the effectiveness of any Required Shelf Registration Statement or any Demand Registration Statement filed pursuant to Section 3.1 shall terminate on the first date on which the Shareholders (i) in the aggregate, hold Shareholder Shares representing less than five percent (5%) of the outstanding Voting Securities (the " Registration Rights Termination Date ") and (ii) are each able to freely sell their remaining Shares under Rule 144 under the Securities Act without regard to the volume, manner of sale or filing requirements of such rule, and as to any Shareholder shall terminate

13


on the earlier of the Registration Rights Termination Date and the first date on which such Shareholder no longer holds Registrable Shares.

         SECTION 3.5     Suspension.     If the filing, initial effectiveness or continued use of a Registration Statement with respect to a Demand Registration or a Shelf Registration would require the Company to make a public disclosure of material non-public information, which disclosure the Company determines in good faith (after consultation with external legal counsel) would materially impact the Company or would materially impede, delay or interfere with on the Company's ability to effect a reasonably imminent material proposed acquisition, disposition, financing, reorganization, recapitalization or similar transaction, then the Company may, upon giving prompt written notice of such determination to the Shareholder, delay the filing or initial effectiveness of, or suspend the use of, as applicable, such Registration Statement or any Prospectus or Free Writing Prospectus; provided , however , that, unless otherwise approved in writing by the Shareholder, the Company shall not be permitted to do so for a period of time in excess of ninety (90) days in the case of any single delay or suspension, and the number of days in any 12-month period on which such a suspension is in effect shall not exceed one hundred twenty (120) (except that such number of days shall not exceed ninety (90) in the 12-month period commencing on the Closing Date (as defined in the Combination Agreement)). In the event that the Company exercises its rights under the preceding sentence, the Shareholder shall suspend, promptly upon receipt of the notice referred to above, the use of any Prospectus or Free Writing Prospectus relating to such Demand Registration or Shelf Registration in connection with any sale or offer to sell Registrable Shares. In the event of such a suspension for which notice is given by the Company after the effectiveness of the applicable Registration Statement, the period specified in clause (A) in Section 3.6(b) (or, in the case of a Required Shelf Registration Statement, the Shelf Period) shall be extended by the number of days of such suspension. The Shareholder shall keep confidential the receipt of any notice under this Section 3.5 and the contents thereof, except as required pursuant to applicable law, and, during any period of such delay or suspension, shall not offer or sell or otherwise transfer any Shareholder Shares or otherwise engage in trading of securities of the Company. Notwithstanding anything to the contrary, upon the commencement of any Scheduled Black-Out Period, the Shareholder shall immediately suspend the use of any Prospectus or Free Writing Prospectus in connection with any sale or offer to sell Registrable Shares until the termination of such Scheduled Black-Out Period.

         SECTION 3.6     Registration Procedures.     Subject to Section 3.1(d) and the Company's right to withdraw or terminate an applicable Piggyback Registration under Section 3.2(a), whenever one or more Shareholders shall have requested in accordance with Section 3.1 or Section 3.2, as applicable, that any Registrable Shares be registered pursuant to Section 3.1 or Section 3.2, as applicable, the Company shall:

14


15


16


        Subject to the limitations on the Company's ability to delay the filing or initial effectiveness of, or suspend the use of, as applicable, a Registration Statement or a Prospectus or Free Writing Prospectus pursuant to Section 3.5, each Shareholder shall, upon receipt of any written notice from the Company of the happening of any event of the kind described in Section 3.6(f), promptly discontinue its disposition of Registrable Shares pursuant to any Registration Statement until such Shareholder's receipt of the copies of the supplemented or amended prospectus contemplated by Section 3.6(f). If any Shareholder is so directed by the Company, such Shareholder shall deliver to the Company (at the Company's expense) all copies, other than permanent file copies, in such Shareholder's possession of the Prospectus covering such Registrable Shares at the time of receipt of such notice. In the event that the Company shall give any such notice, the period mentioned in Section 3.6(b) (or, in the case of a Required Shelf Registration, the Shelf Period), as applicable, shall be extended by the number of days during the period from and including the date of the giving of such notice to and including the date when the Shareholders to which such notice was given shall have been given the copies of the supplemented or amended Prospectus contemplated by Section 3.6(f).

        In the case of any underwritten offering of Registrable Shares registered under a Required Shelf Registration Statement or a Demand Registration Statement filed pursuant to Section 3.1(a), or in the case of a Piggyback Registration under Section 3.2 or a Shelf Registration, (i) all Registrable Shares or Similar Securities to be included in such offering or registration, as the case may be, shall be subject to the applicable underwriting agreement with customary terms (including customary provisions relating to indemnities and contribution), and neither any Shareholder nor any holder of Similar Securities may participate in such offering or registration unless such Person agrees to sell such Person's securities on the basis provided therein; and (ii) neither any Shareholder nor any holder of Similar Securities may participate in such offering or registration unless such Person completes and executes all questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements, custody agreements and other documents reasonably required to be executed in connection therewith, and provides such other information to the Company and the underwriter(s) as may be reasonably requested to offer or register such Person's Registrable Shares or Similar Securities, as the case may be; provided , however , that (A) a Shareholder shall not be required to make any representations or warranties other than those related to title and ownership of, and power and authority to transfer, the Registrable Shares of such Shareholder included therein and such Shareholder's intended method of distribution of such Registrable Shares and as to the accuracy and completeness of statements made in the applicable Registration Statement, Prospectus or other document in reliance upon, and in conformity with, written information prepared and furnished to the Company or the managing underwriter(s) by such Shareholder or its Representatives pertaining to such Shareholder and (B) the aggregate amount of liability of a Shareholder pursuant to any indemnification obligation thereunder shall not exceed the net proceeds received by such Shareholder from such offering. As a condition to including Registrable Shares in any Registration Statement filed in accordance with this Article III , the

17


Company may require that it shall have received an undertaking reasonably satisfactory to the Company from any underwriter to indemnify and hold harmless the Company and its directors, officers and Affiliates to the extent customarily provided by underwriters in connection with similar securities and offerings.

        After any Shareholder has been notified of its opportunity to include Registrable Shares in any Piggyback Registration or of a request, in connection with an offering other than under a Demand Registration, such Shareholder (i) shall treat the Offering Confidential Information as confidential information, (ii) shall not use any Offering Confidential Information for any purpose other than, in the case of a Piggyback Registration, to evaluate whether to include its Registrable Shares in such Piggyback Registration and (iii) shall not disclose any Offering Confidential Information to any Person other than, in the case of a Piggyback Registration, such of its Representatives as have a need to know such Offering Confidential Information in connection with such purpose, which Representatives such Shareholder shall cause to comply with the requirements of this paragraph; provided , however , that such Shareholder may disclose Offering Confidential Information if such disclosure is required by legal process, but such Shareholder shall cooperate with the Company to limit the extent of such disclosure through protective order or otherwise, and to seek confidential treatment of the Offering Confidential Information. Such Shareholder shall not offer or sell or otherwise transfer any Shareholder Shares or otherwise engage in trading of securities of the Company while in possession of Offering Confidential Information.

         SECTION 3.7     Registration Expenses .    

18


         SECTION 3.8     Indemnification; Contribution .    

19


20


         SECTION 3.9     Indemnification Procedures.     

21


         SECTION 3.10     Rule 144; Regulation S.     The Company will use its reasonable efforts to timely file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder, and to take such further action as the Shareholders may reasonably request, all to the extent required from time to time to enable the Shareholder to sell Registrable Shares without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 or Regulation S under the Securities Act or (ii) any similar rule or regulation hereafter adopted by the SEC.

         SECTION 3.11     Holdback.     The Company and each Shareholder agree, in connection with any underwritten offering of equity securities of the Company, upon the written request of the managing underwriter(s) of such offering, not to effect (other than pursuant to such underwritten offering) any public sale or distribution of Shareholder Shares or other equity securities of the Company, including any sale or distribution pursuant to Rule 144 or Rule 144A under the Securities Act, or make any short sale of, loan, grant any option for the purchase of, or otherwise transfer, any Registrable Shares or other equity securities of the Company, in each case during the Holdback Period (and, if (A) during the last seventeen (17) days of the Holdback Period, the Company issues an earnings release or material news or a material event relating to the Company occurs or (B) prior to the expiration of the Holdback Period, the Company announces that it will release earnings results during the sixteen (16) day period beginning on the last day of the Holdback Period, until the expiration of the eighteen (18) day period beginning on the issuance of the earnings release or the announcement of the material news or the occurrence of the material event), without the prior written consent of the managing underwriter(s). The foregoing sentence shall not apply to the Company in connection with (a) any sale, distribution or transfer of equity securities pursuant to a Special Registration, (b) the issuance by the Company of equity securities upon the exercise of an option or warrant or the conversion of a security, (c) the grant or award of any equity securities pursuant to employee benefit or compensation plans of the Company or (d) any equity securities issued or granted pursuant to any nonemployee director benefit or compensation plan or dividend reinvestment plan or share purchase plan.

         SECTION 3.12     Existing Registration Statements.     Notwithstanding anything to the contrary and subject to applicable law and regulation, the Company may satisfy any obligation hereunder to file or use reasonable efforts to file a Registration Statement or to have a Registration Statement become effective by designating, by notice to the applicable Initiating Holders, a Registration Statement that previously has been filed with the SEC or become effective, as the case may be, as the relevant Registration Statement for purposes of satisfying such obligation, and all references to any such obligation shall be construed accordingly; provided that such previously filed Registration Statement may be amended or, subject to applicable securities laws, supplemented to add the number of Registrable Shares, and, to the extent necessary, to identify selling securityholders thereunder. To the extent this Agreement refers to the filing or effectiveness of other Registration Statements by or at a specified time and the Company has, in lieu of then filing such Registration Statements or having such Registration Statements become effective, designated a previously filed or effective Registration Statement as the relevant Registration Statement for such purposes, in accordance with the preceding sentence, such references shall be construed to refer to such designated Registration Statement, as amended.

22


ARTICLE IV
MISCELLANEOUS

         SECTION 4.1     Shareholder Actions.     Any determination, consent or approval of, or notice or request delivered by, or any other action of, any Shareholder shall be made by, and shall be valid and binding upon, all Shareholders, if made by one or more Shareholders Beneficially Owning a majority of the Shareholder Shares. The Company shall be entitled to demand from time to time and at any time, from the Shareholders, evidence reasonably satisfactory to the Company of such majority approval before proceeding with the Company's obligations under this Agreement.

         SECTION 4.2     Joint and Several Liability.     The Shareholders hereby agree that all representations, warranties, covenants, agreements, liability and obligations under this Agreement are joint and several to the Shareholders, and each Shareholder will be liable to the fullest extent provided for in this Agreement for any breach, default, liability or other obligation of each of the other Shareholders.

         SECTION 4.3     Injunctive Relief.     Each party hereto acknowledges that it would be impossible to determine the amount of damages that would result from any breach of any of the provisions of this Agreement and that the remedy at law for any breach, or threatened breach, of any of such provisions would likely be inadequate and, accordingly, agrees that the other parties shall, in addition to any other rights or remedies which they may have, be entitled to such equitable and injunctive relief as may be available from any court of competent jurisdiction to compel specific performance of, or restrain any party from violating, any of such provisions. In connection with any action or proceeding for injunctive relief, each party hereto hereby waives the claim or defense that a remedy at law alone is adequate and agrees, to the maximum extent permitted by law, to have each provision of this Agreement specifically enforced against it, without the necessity of posting bond or other security against it, and consents to the entry of injunctive relief against it enjoining or restraining any breach or threatened breach of such provisions of this Agreement.

         SECTION 4.4     Assignments.     This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. None of the parties may directly or indirectly assign any of their rights or delegate any of their obligations under this Agreement without the prior written consent of the other parties, other than a transfer by a Shareholder to a Permitted Transferee (as defined in the Shareholders' Agreement), which shall not require the prior written consent of the other parties. Any purported direct or indirect assignment in violation of this Section 4.4 shall be null and void ab initio.

         SECTION 4.5     Amendments; Waiver.     No amendment, modification or discharge of this Agreement, and no waiver hereunder, shall be valid or binding unless set forth in writing and duly executed by (i) the Company, where enforcement of the amendment, modification, discharge or waiver is sought against the Company; or (ii) each Shareholder, where enforcement of the amendment, modification, discharge or waiver is sought against the Shareholders. Any such waiver shall constitute a waiver only with respect to the specific matter described in such writing and shall in no way impair the rights of the party granting such waiver in any other respect or at any other time. The waiver by the Company or the Shareholders of a breach of or a default under any of the provisions of this Agreement or the failure to exercise or delay in exercising any right or privilege hereunder, shall not be construed as a waiver of any other breach or default of a similar nature, or as a waiver of any of such provisions, rights or privileges hereunder. The rights and remedies herein provided are cumulative and none is exclusive of any other, or of any rights or remedies that any party may otherwise have at law or in equity.

         SECTION 4.6     Notices.     Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in writing and shall be deemed given to a party when

23


(i) delivered to the appropriate address by hand or by nationally recognized overnight courier service; (ii) sent by facsimile with confirmation of transmission by the transmitting equipment; or (iii) sent by electronic mail (with return receipt received), in each case, to the following addresses, electronic mail addresses or facsimile numbers and marked to the attention of the person (by name or title) designated below, or to such other persons or addresses as may be designated in writing by the party to receive such notice as provided below:

24


         SECTION 4.7     Governing Law; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury.     THIS AGREEMENT AND ANY DISPUTE ARISING OUT OF OR IN CONNECTION WITH IT OR ITS SUBJECT MATTER OR FORMATION INCLUDING NON-CONTRACTUAL DISPUTES OR CLAIMS SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. Each party hereto irrevocably agrees that the state and federal courts located in the state of New York are to have exclusive jurisdiction to settle any dispute arising out of or in connection with this Agreement and, for such purposes, irrevocably submits to the exclusive jurisdiction of such courts. Any proceeding, suit or action arising out of or in connection with this Agreement (" Proceedings ") shall therefore be brought exclusively in any state federal court located in the state of New York. Solely in connection with claims arising under this Agreement or the transactions that are the subject of this Agreement, each party irrevocably (i) waives any objection to Proceedings in such courts on the grounds of venue or on the grounds of forum non conveniens and (ii) agrees that service of process upon such party in any such Proceeding shall be effective if notice is given in accordance with Section 4.6. EACH PARTY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

         SECTION 4.8     Interpretation.     The table of contents and headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions hereof. The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event that an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement. In the event of any conflict or inconsistency between the provisions of this Agreement and the articles of association of the Company, the terms of this Agreement shall prevail.

         SECTION 4.9     Entire Agreement; No Other Representations.     This Agreement constitutes the entire agreement, and supersedes all prior agreements, understandings representations and warranties both written and oral, between or among the parties with respect to the subject matter hereof.

         SECTION 4.10     No Third-Party Beneficiaries.     Except as explicitly provided for in Section 3.8 and Section 3.9, this Agreement is not intended to confer upon any Person other than the parties hereto any rights or remedies hereunder.

         SECTION 4.11     Severability.     The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application thereof to any Person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision; and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction.

         SECTION 4.12     Counterparts.     This Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement.

         SECTION 4.13     Further Assurances.     Upon the terms and subject to the conditions set forth in this Agreement, from and after the Effective Date, the parties hereto shall each use reasonable efforts to promptly (i) take, or to cause to be taken, all actions, and to do, or to cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable under applicable law or otherwise to consummate and make effective the transactions contemplated by this Agreement; (ii) obtain from any governmental or regulatory authority or third party any and all

25


necessary clearances, waivers, consents, authorizations, approvals, permits or orders required to be obtained in connection with the performance of this Agreement and the consummation of the transactions contemplated hereby; and (iii) execute and deliver any additional instruments necessary to consummate the transactions contemplated by this Agreement.

[The reminder of this page is intentionally left blank.]

26


        IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the date first written above.

    CF B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

27


    CAPRICORN CAPITAL B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

28


    CAPRICORN CAPITAL B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

29


    LEO CAPITAL B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

30


    LEO CAPITAL B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

31


    AQUARIUS INVESTMENTS B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

32


    AQUARIUS INVESTMENTS B.V.

 

 

By:

 

 

        Name:    
        Title:    

   

[ Signature Page to Registration Rights Agreement ]

33




QuickLinks

SECOND AMENDMENT TO COMBINATION AGREEMENT
W I T N E S S E T H
21 DECEMBER 2015 UNOFFICIAL ENGLISH TRANSLATION ARTICLES OF ASSOCIATION CF N.V.
NOTE ABOUT TRANSLATION
Schedule A
Schedule B
TABLE OF CONTENTS
W I T N E S S E T H
TABLE OF CONTENTS
W I T N E S S E T H

QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 2.2


SECOND AMENDMENT TO SHAREHOLDERS' AGREEMENT

        THIS SECOND AMENDMENT, dated as of December 20, 2015 (this " Second Amendment "), to the Shareholders' Agreement, dated as of August 6, 2015 (as amended, the " Shareholders' Agreement "), by and among Darwin Holdings Limited, a private company limited by shares incorporated under the law of England (" Darwin Holdings "), OCI N.V., a public company with limited liability ( naamloze vennootschap ) incorporated under the law of The Netherlands (" Oxford "), CF B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated under the law of The Netherlands, with its corporate seat ( statutaire zetel ) in Amsterdam, The Netherlands (the " Company "), Capricorn Capital B.V., a private limited liability company incorporated under the laws of The Netherlands (registered number 56929870) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Capricorn "), Leo Capital B.V., a private limited liability company incorporated under the laws of The Netherlands (registered number 56929315) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Leo "), and Aquarius Investments B.V., a private limited liability company incorporated under the laws of The Netherlands (registered number 56929102) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Aquarius " and, together with Leo and Capricorn, the " S Shareholders " and, together with Oxford, the " Shareholders "). Each of Darwin Holdings, Oxford, Capricorn, Leo and Aquarius are referred to herein as a " Party " and together the " Parties ". Capitalized terms used but not defined herein shall have the meanings given to such terms in the Shareholders' Agreement.


WITNESSETH:

        WHEREAS, the Parties entered into the Shareholders Agreement;

        WHEREAS, the Parties entered into an Amendment to the Shareholders' Agreement, dated as of November 6, 2015 (the " Amendment "); and

        WHEREAS, pursuant to Clause 9.12 of the Shareholders' Agreement, the Parties desire to amend and restate in its entirety the Shareholders' Agreement as set forth in Exhibit A to, among others, reflect the addition of the Company as a party to the Shareholders' Agreement and to remove Darwin Holdings as a party to the Shareholders' Agreement.

        NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby expressly acknowledged, and subject to the terms and conditions hereof, the parties hereto agree as follows:

1.
Amended and Restated Shareholders' Agreement . The Shareholders' Agreement is hereby amended and restated in its entirety as set forth in Exhibit A hereto. From and after the date hereof, the parties to the Shareholders' Agreement shall be the Company, Capricorn, Leo, Aquarius and Oxford, each of which is concurrently herewith executing the amended and restated Shareholders' Agreement.

2.
Shareholders' Agreement in Full Force and Effect . Except as expressly provided hereby, this Second Amendment shall not constitute a waiver or amendment of any term or condition of the Shareholders' Agreement, or any documents delivered pursuant thereto, and all such terms and conditions shall remain in full force and effect and are hereby ratified and confirmed in all respects.

3.
Release . Each of the Parties, other than Darwin Holdings, hereby irrevocably and unconditionally releases and forever discharges Darwin Holdings and its respective Affiliates and each of their respective Representatives, successors and assigns (collectively, the " Releasees ") from any and all claims or proceedings, whether or not now known or anticipated, which the Parties, other than

4.
Counterparts; Effectiveness . This Second Amendment may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which, when taken together, shall constitute one and the same instrument. This Second Amendment shall become effective when each party hereto shall have received counterparts thereof signed and delivered by the other parties hereto. Signatures transmitted electronically shall be accepted as originals for all purposes of this Second Amendment.

[ Signature pages follow ]

2


        IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to be executed as of the date first written above.

    CF INDUSTRIES HOLDINGS, INC.

 

 

 

 

 
    By:   /s/ W. ANTHONY WILL

Name: W. Anthony Will
Title:    President and Chief Executive Officer

   

[ Signature Page to Amendment No. 2 to Shareholders' Agreement ]


    DARWIN HOLDINGS LIMITED

 

 

 

 

 
    By:   /s/ DOUGLAS C. BARNARD

Name: Douglas C. Barnard
Title:    Chairman

   

[ Signature Page to Amendment No. 2 to Shareholders' Agreement ]


    OCI N.V.

 

 

 

 

 
    By:   /s/ SALMAN BUTT

Name: Salman Butt
Title:    Chief Financial Officer

   

[ Signature Page to Amendment No. 2 to Shareholders' Agreement ]


    CF B.V.

 

 

 

 

 
    By:   /s/ DOUGLAS C. BARNARD

Name: Douglas C. Barnard
Title:    Managing Director

   

[ Signature Page to Amendment No. 2 to Shareholders' Agreement ]


    CAPRICORN CAPITAL B.V.

 

 

 

 

 
    By:   /s/ P. OOSTHOEK

Name: P. Oosthoek
Title:    Proxyholder

 

 

 

 

 
    By:   /s/ G.A.R. WARRIS

Name: G.A.R. Warris
Title:    Proxyholder

   

[ Signature Page to Amendment No. 2 to Shareholders' Agreement ]


    LEO CAPITAL B.V.

 

 

 

 

 
    By:   /s/ P. OOSTHOEK

Name: P. Oosthoek
Title:    Proxyholder

 

 

 

 

 
    By:   /s/ G.A.R. WARRIS

Name: G.A.R. Warris
Title:    Proxyholder

   

[ Signature Page to Amendment No. 2 to Shareholders' Agreement ]


    AQUARIUS INVESTMENTS B.V.

 

 

 

 

 
    By:   /s/ P. OOSTHOEK

Name: P. Oosthoek
Title:    Proxyholder

 

 

 

 

 
    By:   /s/ G.A.R. WARRIS

Name: G.A.R. Warris
Title:    Proxyholder

   

[ Signature Page to Amendment No. 2 to Shareholders' Agreement ]


Exhibit A

         DATED December 20, 2015
CF B.V.,
CAPRICORN CAPITAL B.V.,
LEO CAPITAL B.V.,
AQUARIUS INVESTMENTS B.V.
AND
OCI N.V.
AMENDED AND RESTATED SHAREHOLDERS' AGREEMENT

1


This Agreement (this " Agreement ") is made on December 20, 2015

BY AND AMONG:

(1)
CF B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 64782573) whose registered office is at Prins Bernhardplein 200, 1097 JB, Amsterdam, The Netherlands (the " Company ");

(2)
OCI N.V. , a public company with limited liability ( naamloze vennootschap ) incorporated under the law of The Netherlands (registered number 56821166) whose registered office is at Honthorststraat 19, 1071 DC Amsterdam, The Netherlands (" Oxford ");

(3)
Capricorn Capital B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 56929870) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Capricorn ");

(4)
Leo Capital B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 56929315) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Leo "); and

(5)
Aquarius Investments B.V. , a private limited liability company incorporated under the laws of The Netherlands (registered number 56929102) whose registered office is at Prins Bernhardplein 200, 1097 JB Amsterdam, The Netherlands (" Aquarius " and, together with Leo and Capricorn, the " S Shareholders " and, together with Oxford, the " Shareholders ").

WHEREAS:

(A)
CF Industries Holdings, Inc., a Delaware corporation (" Cambridge "), the Company, Finch Merger Company LLC, a Delaware limited liability company and wholly-owned, direct or indirect, subsidiary of the Company (" MergerCo "), and Oxford are parties to that certain Combination Agreement, dated as of August 6, 2015, as amended (the " Combination Agreement ");

(B)
Pursuant to the Combination Agreement, among other things: (i) Oxford will contribute to the Company certain equity ownership interests in certain Persons owned, directly or indirectly, by Oxford, in exchange for consideration consisting, in part, of Ordinary Shares (as defined below) to be issued by the Company to Oxford, (ii) a portion of the Ordinary Shares issued by the Company to Oxford will be distributed by Oxford to its shareholders (the " Distribution ") and (iii) MergerCo will merge with and into Cambridge, with Cambridge becoming a wholly-owned, direct or indirect, subsidiary of the Company whereby the shares of Cambridge common stock will be converted into the right to receive a certain ratio of Ordinary Shares upon the terms and conditions set forth in the Combination Agreement; and

(C)
The Company and the Shareholders desire to establish in this Agreement certain terms and conditions concerning the Ordinary Shares to be owned directly or indirectly by the Shareholders as of and after the Closing and related provisions concerning the Shareholders' relationship with and investment in the Company as of and after the Closing.

2


IT IS AGREED as follows:

1.     Interpretation

        In this Agreement:

1.1   Definitions

        " Affiliate " means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, Controls, or is Controlled by, or is under Common Control with, such Person, provided that neither the Shareholders, nor any of their Subsidiaries shall be deemed to be an Affiliate of the Company or vice versa, and provided, further, that solely for purposes of this Agreement, any settlor of a Family Trust shall be deemed to be an Affiliate of such Family Trust;

        " Articles " mean the articles of association of the Company, as amended from time to time in accordance with the provisions of this Agreement;

        " Associate " means, with respect to any Person, (i) any Person of which such Person is an officer, partner or equivalent or is, directly or indirectly, the beneficial owner of ten per cent. (10%) or more of any class of equity securities, (ii) any trust or other estate in which such Person has a substantial beneficial interest or as to which such Person serves as trustee or in a similar fiduciary capacity, and (iii) any Family Member or spouse of such Person;

        " Beneficially Own " means, with respect to any securities, having "beneficial ownership" of such securities for purposes of Rule 13d-3 or 13d-5 under the Exchange Act (as in effect on the date of this Agreement and (ii) having the right to become the Beneficial Owner of such securities (whether such right is exercisable immediately or only after the passage of time or the occurrence of conditions) pursuant to any agreement, arrangement or understanding, or upon the exercise of conversion rights, exchange rights, rights, warrants or options, or otherwise. The terms " Beneficial Owner ", " Beneficial Ownership " and " Beneficially Owned " shall have a correlative meaning;

        " Board " means, as of any date, the board of directors of the Company on such date;

        " Business Day " means a day which is not a Saturday or Sunday or a bank or public holiday in New York, New York or The Netherlands;

        " Capricorn " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of Capricorn are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees;

        " Closing " has the meaning given to such term in the Combination Agreement;

        " Combination Agreement " has the meaning given to such term in the recitals to this Agreement;

        " Competitor " means any Person set forth on Schedule A;

        " Control " (including, with correlative meanings, " Controlled by " and " under Common Control with ") means the possession, direct or indirect, of the power to direct or cause the direction of management or policies of a Person, whether through ownership of securities, by contract or otherwise;

        " Director " means any member of the Board;

        " Directed Offering " means any so-called "registered direct" sale, block trade or other similar offering or Transfer made pursuant to an effective registration statement filed under the Securities Act, but in which the Voting Securities Transferred are not directly or indirectly widely distributed, and the Shareholder making such Transfer has knowledge of the identity of each transferee;

        " Distribution " has the meaning given to such term in the recitals to this Agreement;

3


        " Effective Time " has the meaning given to such term in the Combination Agreement;

        " Exchange Act " means the U.S. Securities Exchange Act of 1934, as amended;

        " Family Member " with respect to any individual, means such individual's mother, father, sisters, brothers and children;

        " Family Trust " means a trust for the benefit of one or more S Family Members;

        " Firewater One Shareholder Agreement " has the meaning given to such term in the Combination Agreement;

        " Group " has the meaning assigned to such term in Section 13(d)(3) of the Exchange Act and Rule 13d-5(b) thereunder;

        " Ordinary Shares " means the ordinary shares of the Company;

        " Organisational Documents " means, with respect to any Person:

        " Other Shares " means shares of any class of share capital of the Company (other than Ordinary Shares) that are entitled to vote on the appointment or removal of Directors;

        " Ownership Limit " means, at any time of determination, twenty point five per cent. (20.5%) of the Voting Securities outstanding at such time, computed without regard to any Oxford Shares;

        " Ownership Threshold " means, at any time of determination, five per cent. (5%) of the Voting Securities outstanding at such time;

        " Oxford " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of Oxford are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees;

        " Oxford Shares " means the Ordinary Shares acquired by Oxford (i) pursuant to the Combination Agreement and not included in the Distribution and (ii) pursuant to the Firewater One Shareholder Agreement, if any;

        " Permitted Transferee " means the Company or any direct or indirect wholly-owned Subsidiary or Controlled Affiliate of any Shareholder, and in the case of Oxford, any shareholder of Oxford who receives Voting Securities pursuant to a pro rata distribution by Oxford after the Effective Time, and in the case of an S Shareholder, (i) an S Family Member, (ii) a Family Trust, or (iii) any direct or indirect wholly-owned Subsidiary or Controlled Affiliate of the foregoing;

4


        " Person " means any individual, private or public company, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organisation, governmental entity or other entity of any kind or nature;

         "Qualified Candidate" means an individual who:

        " Registration Rights Agreements " has the meaning set forth in the Combination Agreement;

        " Representatives " means, with respect to any designated Person, such designated Person's Affiliates and the respective directors, officers, employees, accountants, counsel, consultants and other agents and advisers of such designated Person and its Affiliates;

        " S Family Member " means any of Onsi Naguib Sawiris, his children and remoter issue or the spouses of any of them;

        " SEC " means the United States Securities and Exchange Commission;

        " Securities Act " means the United States Securities Act of 1933, as amended;

        " Shareholder Affiliated Persons " has the meaning given to such term in Clause 5;

        " Shareholder Shares " means Voting Securities Beneficially Owned by the S Shareholders or by Oxford, as the case may be;

        " S Shareholders " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of any S Shareholders are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees;

        " Shareholders " has the meaning given to such term in the preamble to this Agreement and, in the event that Shareholder Shares of any Shareholders are Transferred to any Permitted Transferees in accordance with Clause 4.1(c)(iv), shall include such Permitted Transferees, and in the event that Shareholder Shares of any Shareholders are Transferred in accordance with Clause 4.1(c)(v)(A), shall include such transferees;

        " Standstill Period " has the meaning given to such term in Clause 3.1;

        " Subsidiary " has the meaning set forth in the Combination Agreement;

        " Transfer " means any voluntary or involuntary sale, transfer, assignment, pledge, hypothecation, charge, mortgage, license, gift, creation of a security interest in or lien on, grant of any right or option, creation of any convertible, exchangeable or derivative security with respect to, placement in trust (voting or otherwise), encumbrance or other disposition of any kind to any Person, including those by way of hedging or derivative transactions, in each case, directly or indirectly, including by means of a disposition of any equity interests in an S Shareholder or in a Person that directly or indirectly holds any equity interests in an S Shareholder, by operation of law or otherwise, provided , however , that a

5


"Transfer" shall not include any direct or indirect transfer of the equity securities or Control of Oxford. Notwithstanding the foregoing, any direct or indirect mortgage, pledge, hypothecation, encumbrance or any other similar disposition of the nature of a security interest, lien or charge contemplated by the first sentence of this definition, by a Shareholder of any Ordinary Shares, or with respect to any such Ordinary Shares, shall not be deemed to constitute a "Transfer" subject to the restrictions on Transfer contained or referenced herein. The term " Transferred " shall have a correlative meaning; and

        " Voting Securities " means the Ordinary Shares together with any Other Shares.

1.2   Subordinate legislation

        References to a statutory provision include any subordinate legislation made from time to time under that provision.

1.3   Modification etc. of statutes

        References to a statute or statutory provision include that statute or provision as from time to time modified or re-enacted or consolidated.

1.4   Clauses, Schedules etc.

        References to this Agreement include the Schedules to it and this Agreement as from time to time amended and references to Clauses and Schedules are to Clauses of and Schedules to this Agreement, unless the context otherwise require.

1.5   Headings

        Headings shall be ignored in construing this Agreement.

1.6   Parties

        Any reference in this Agreement to a " party " or " parties " shall be a reference to a party or parties to this Agreement.

1.7   Effectiveness of this Agreement

        This Agreement, other than this Clause 1, Clause 2 and Clauses 7 to 9 (which will come into force immediately), will take effect at and as of the Effective Time. Notwithstanding anything to the contrary herein, in the event the Combination Agreement is terminated in accordance with its terms prior to the Effective Time, this Agreement shall terminate immediately and be null and void.

1.8   General interpretation

6


1.9   Actions at the Effective Time

        Upon completion of the Distribution, the S Shareholders shall update Schedule B to reflect all Voting Securities Beneficially Owned by the S Shareholders at such time.

2.     Warranties

2.1   Warranties of the Company

        The Company warrants to the Shareholders as of the date hereof that:

7


2.2   Warranties of the Shareholders

        Each Shareholder warrants, severally, and not jointly, to the Company as of the date hereof that:

8


3.     Standstill; share ownership related information

3.1   Standstill restrictions

        From and after the Effective Time until the one (1) year anniversary of the date on which the S Shareholders, in the aggregate, cease to Beneficially Own Voting Securities representing at least the Ownership Threshold (the " Standstill Period "), each Shareholder agrees that, without the prior written consent of the Board, such Shareholder shall not, and shall cause each of its and their Affiliates and, shall use reasonable endeavours to cause, its and their Representatives acting on their behalf not to, directly or indirectly, alone or acting together with any other Person, except as otherwise (A) expressly set forth in this Clause 3.1 or (B) provided in the Combination Agreement and/or the Firewater One Shareholder Agreement:

9


3.3   Share ownership related information

        For so long as this Agreement is in effect, each Shareholder shall, upon request in writing by the Company, provide to the Company as soon as reasonably practicable and in any event within ten (10) Business Days, any information related to such Shareholder's ownership or holding of Shareholder Shares, including any agreements or arrangements relating to such ownership or holding.

10


4.     Transfer restrictions

4.1   Transfer restrictions

11


12


5.     Freedom to pursue opportunities

        Notwithstanding anything in this Agreement to the contrary, the parties expressly acknowledge and agree that: (a) each Shareholder and its Affiliates (collectively, the " Shareholder Affiliated Persons ") has the right to, and shall have no duty (contractual or otherwise) not to, directly or indirectly engage in the same or similar business activities or lines of business as the Company or any of its Subsidiaries, including those deemed to be competing with the Company or any of its Subsidiaries, and (b) in the event that a Shareholder Affiliated Person acquires knowledge of a potential transaction or matter that may be a corporate opportunity for each of the Company and such Shareholder Affiliated Person, shall have no duty (contractual or otherwise) to communicate or present such corporate opportunity to the Company or any of its Subsidiaries, as the case may be, and shall not be liable to the Company or its Affiliates or shareholders for breach of any duty (contractual or otherwise) by reason of the fact that such Shareholder Affiliated Person, directly or indirectly, pursues or acquires such opportunity for itself, directs such opportunity to another Person, or does not present such opportunity to the Company.

6.     Termination

        This Agreement shall terminate with immediate effect upon the earlier of (a) the date that is one (1) year after the first date on which the S Shareholders, in the aggregate, shall cease to Beneficially Own Voting Securities representing at least the Ownership Threshold; and (b) the date not less than the date five (5) years after the date hereof that the Company elects to terminate this Agreement by giving written notice to the Shareholders; provided that this Clause 6 and Clauses 7 and 8 shall remain in full force and effect following such termination.

7.     Notices

7.1   Addresses

        Any notice or other communication to be given under this Agreement shall be in writing, shall be deemed to have been duly served on, given to or made in relation to a party if it is left at the authorised address of that party, posted by first class mail addressed to that party at such address, or sent by facsimile transmission to a machine situated at such address and shall if:

        For the purposes of this Clause 7 the authorised address of each party shall be the address set out below or such other address (and details) as that party may notify to the others in writing from time to time in accordance with the requirements of this Clause 7:

13


To the Company:

CF B.V.
c/o
CF Industries Holdings, Inc.
4 Parkway North, Suite 400
Deerfield, IL 60015-2590
Telephone: (847) 405-2400
Facsimile: (847) 405-2711
Email: Dbarnard@cfindustries.com
Attention: Douglas C. Barnard
With copies (which shall not constitute notice) to:
Skadden, Arps, Slate, Meagher & Flom LLP
155 North Wacker Drive
Chicago, Illinois 60606
Telephone: (312) 407-0700
Facsimile: (312) 407-0411
Email: brian.duwe@skadden.com, richard.witzel@skadden.com
Attention: Brian W. Duwe, Richard C. Witzel, Jr.
To any of the Shareholders:
Intertrust Netherlands BV
Prins Bernhardplein 200
1097 JB Amsterdam
The Netherlands
Telephone: + 31 20 521 4777
Email: jurjen.hardeveld@intertrustgroup.com
Attention: Jurjen Hardeveld
With copies (which shall not constitute notice) to:
Withers LLP
16 Old Bailey
London EC4M 7EG
United Kingdom
Telephone: +44 (0)20 7597 6116
Email: Samantha.Morgan@withersworldwide.com
Attention: Samantha Morgan
Cleary Gottlieb Steen & Hamilton LLP
One Liberty Plaza
New York, NY 10006
Telephone: (212) 225-2000

14


Facsimile: (212) 225-3999
Email: rdavis@cgsh.com, ptiger@cgsh.com
Attention: Robert P. Davis, Paul M. Tiger
To Oxford:
OCI N.V.
Honthorststraat 19
1071 DC Amsterdam
The Netherlands
Facsimile: +44 (0) 20 7439 4802
Email: Erika.Wakid@oci.nl
Attention: Erika Wakid
With copies (which shall not constitute notice) to:
Cleary Gottlieb Steen & Hamilton LLP
One Liberty Plaza
New York, NY 10006
Telephone: (212) 225-2000
Facsimile: (212) 225-3999
Email: rdavis@cgsh.com, ptiger@cgsh.com
Attention: Robert P. Davis, Paul M. Tiger

8.     General

8.1   Whole agreement

        This Agreement contains the whole agreement between the parties hereto relating to the subject matter hereof at the date hereof to the exclusion of any terms implied by law which may be excluded by contract and supersedes any previous written or oral agreement between the parties in relation to the matters dealt with herein.

8.2   No inducement

        Each party to this Agreement acknowledges that it has not been induced to enter into this Agreement by any representation, warranty or undertaking not expressly provided for in this Agreement.

8.3   Legal advice

        Each party to this Agreement confirms it has received independent legal advice relating to all the matters provided for in this Agreement, including the provisions of this Clause 8.3, and agrees, having considered the terms of this Clause 8.3, and this Agreement as a whole, that the provisions of this Clause 8.3, are fair and reasonable.

15


8.4   Survival of rights, duties and obligations

        Termination of this Agreement for any cause shall not release a party from any liability which at the time of termination has already accrued to another party or which thereafter may accrue in respect of any act or omission prior to such termination.

8.5   Conflict with the Articles

        To the extent permitted by law, in the event of any ambiguity or discrepancy between the provisions of this Agreement and the Articles, it is intended that the provisions of this Agreement shall prevail and accordingly the Shareholders shall exercise all voting and other rights and powers available to them so as to give effect to the provisions of this Agreement and shall further if necessary procure any required amendment to the Articles.

8.6   Several and not joint liability of Shareholders

        Each party hereby agrees that the representations, warranties, covenants and agreements of the Shareholders under this Agreement are being made severally, and not jointly, by the Shareholders, and no Shareholder will be liable for any breach, default, liability or other obligation of any of the other Shareholders.

8.7   No partnership

        Nothing in this Agreement shall be deemed to constitute a partnership between the parties nor constitute any party the agent of any other party for any purpose except as expressly provided in this Agreement.

8.8   Shareholder actions

        Any determination, consent or approval of, or notice or request delivered by, or any other action of, any S Shareholder shall be made by, and shall be valid and binding upon, all S Shareholders, if made by one or more S Shareholders Beneficially Owning a majority of the aggregate amount of the Shareholder Shares Beneficially Owned by the S Shareholders. The Company shall be entitled to demand from time to time and at any time, from the S Shareholders, evidence reasonably satisfactory to the Company of such majority approval before proceeding with the Company's obligations under this Agreement.

8.9   Amendments and waiver

        No amendment, modification or discharge of this Agreement, and no waiver hereunder, shall be valid or binding unless set forth in writing and duly executed by the Company, where enforcement of the amendment, modification, discharge or waiver is sought against the Company; or (ii) each Shareholder, where enforcement of the amendment, modification, discharge or waiver is sought against the Shareholders. Any waiver shall constitute a waiver only with respect to the specific matter described in such writing and shall in no way impair the rights of the party granting such waiver in any other respect or at any other time. The waiver by the Company or the Shareholders of a breach of or a default under any of the provisions of this Agreement or the failure to exercise or delay in exercising any right or privilege hereunder, shall not be construed as a waiver of any other breach or default of a similar nature, or as a waiver of any of such provisions, rights or privileges hereunder. The rights and remedies herein provided are cumulative and none is exclusive of any other, or of any rights or remedies that any party may otherwise have at law or in equity.

16


8.10 Assignment

        This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. Except as contemplated by Clause 4.1(c)(iv), none of the parties may directly or indirectly assign any of their rights or delegate any of their obligations under this Agreement without the prior written consent of the other parties. Any purported direct or indirect assignment in violation of this Clause 8.10 shall be null and void ab initio .

8.11 Further assurance

        At any time after the date of this Agreement the parties shall, and shall use all reasonable endeavours to procure that any necessary third party shall, at the cost of the relevant party execute such documents and do such acts and things as that party may reasonably require for the purpose of giving to that party the full benefit of all the provisions of this Agreement.

8.12 Invalidity

        If any provision in this Agreement shall be held to be illegal, invalid or unenforceable, in whole or in part, under any enactment or rule of law, such provision or part shall to that extent be deemed not to form part of this Agreement but the legality, validity and enforceability of the remainder of this Agreement shall not be affected.

8.13 Counterparts

        This Agreement may be entered into in any number of counterparts, all of which taken together shall constitute one and the same instrument. Any party may enter into this Agreement by signing any such counterpart.

8.14 Costs

        Each party shall bear all costs incurred by it in connection with the preparation, negotiation and entry into this Agreement and the documents to be entered into pursuant to it.

9.     Governing law and submission to jurisdiction

9.1   Governing law

        This agreement and any non-contractual obligation arising out of or in connection with it are governed exclusively by Dutch law, without regard to the conflict of laws thereof.

9.2   Jurisdiction

        All disputes arising out of or in connection with this agreement, including disputes concerning its existence, its validity and any non-contractual obligation, will be resolved by the courts in Amsterdam, the Netherlands.

17


In witness whereof this Agreement has been duly executed.

Signed for and on behalf of CF B.V. by:

/s/ DOUGLAS C. BARNARD

   
Name   Douglas C. Barnard    
Title   Managing Director    

18


Signed for and on behalf of OCI N.V. by:

/s/ SALMAN BUTT

   
Name   Salman Butt    
Title   Chief Financial Officer    

19


Signed for and on behalf of Leo Capital B.V. by:

/s/ G.A.R. WARRIS

   
Name   G.A.R. Warris    
Title   Proxyholder    

Signed for and on behalf of Leo Capital B.V. by:

/s/ P. OOSTHOEK

   
Name   P. Oosthoek    
Title   Proxyholder    

20


Signed for and on behalf of Capricorn Capital B.V. by:

/s/ G.A.R. WARRIS

   
Name   G.A.R. Warris    
Title   Proxyholder    

Signed for and on behalf of Capricorn Capital B.V. by:

/s/ P. OOSTHOEK

   
Name   P. Oosthoek    
Title   Proxyholder    

21


Signed for and on behalf of Aquarius Investments B.V. by:

/s/ G.A.R. WARRIS

   
Name   G.A.R. Warris    
Title   Proxyholder    

Signed for and on behalf of Aquarius Investments B.V. by:

/s/ P. OOSTHOEK

   
Name   P. Oosthoek    
Title   Proxyholder    

22



Schedule A

The Mosaic Company
OJSC "Phosagro"
BASF SE
LyondellBasell Industries N.V.
Honeywell International Inc.
Fertilizantes Heringer S.A.
Grupo Fertipar LTDA
PJSC Uralkali
Glencore plc
Archer-Daniels-Midland Company
HELM AG
Ameropa AG
Keytrade AG
Marubeni Corporation
Saudi Arabian Fertilizer Company / Saudi Basic Industries Corporation
Yara International ASA
Potash Corporation of Saskatchewan Inc.
Qatar Fertiliser Company S.A.Q
PT Pupuk Indonesia (Persero)
Koch Industries, Inc.
OCI N.V.
Agrium Inc.
PETRONAS Chemicals Group Berhard
PetroChina Company Limited
Trammo Inc.
TogliattiAzot Corporation
Borealis AG
Sinofert Holdings Limited
Group DF Limited
EuroChem Group AG
China BlueChemical Ltd.
JSC Acron
Hubei Yihua Fertilizer Co., Ltd.
Indian Farmers Fertiliser Cooperative Limited
Methanol Holdings (Trinidad) Limited

23



Schedule B

S Shareholder Oxford Shares:    
Capricorn Capital B.V.    60,672,376
Leo Capital B.V.    36,491,859
Aquarius Investments B.V.    11,522,425

Oxford Shares held by Affiliates of the S Shareholders:
Onsi Sawiris   51
Nassef Sawiris   68,000
NNS Holding   1,105,723
OS Holding   25,000

OCI N.V. 3.875 per cent. Convertible Bonds due 2018:
NNS Holding   €53,300,000

24




QuickLinks

SECOND AMENDMENT TO SHAREHOLDERS' AGREEMENT
WITNESSETH
Schedule A
Schedule B